<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75053</article-id><article-id pub-id-type="doi">10.7554/eLife.75053</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-259906"><name><surname>Dave</surname><given-names>Chintan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4371-7645</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-59119"><name><surname>Mei</surname><given-names>Shirley HJ</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259907"><name><surname>McRae</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259908"><name><surname>Hum</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-277170"><name><surname>Sullivan</surname><given-names>Katrina J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259909"><name><surname>Champagne</surname><given-names>Josee</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259910"><name><surname>Ramsay</surname><given-names>Tim</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8478-8170</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-57784"><name><surname>McIntyre</surname><given-names>Lauralyn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7421-1407</contrib-id><email>lmcintyre@ohri.ca</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02grkyz14</institution-id><institution>Division of Critical Care Medicine, Department of Medicine, Western University</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>Canada</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03c62dg59</institution-id><institution>Regenerative Medicine Program, Ottawa Hospital Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Ottawa</named-content></addr-line><country>Canada</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03c62dg59</institution-id><institution>Knowledge Synthesis Group, Ottawa Hospital Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Ottawa</named-content></addr-line><country>Canada</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03c4mmv16</institution-id><institution>University of Ottawa</institution></institution-wrap><addr-line><named-content content-type="city">Ottawa</named-content></addr-line><country>Canada</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03c62dg59</institution-id><institution>Clinical Epidemiology, Ottawa Hospital Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Ottawa</named-content></addr-line><country>Canada</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03c4mmv16</institution-id><institution>Division of Critical Care, Department of Medicine, University of Ottawa</institution></institution-wrap><addr-line><named-content content-type="city">Ottawa</named-content></addr-line><country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Méndez-Ferrer</surname><given-names>Simón</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>15</day><month>07</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e75053</elocation-id><history><date date-type="received" iso-8601-date="2021-10-28"><day>28</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-06-05"><day>05</day><month>06</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-02-28"><day>28</day><month>02</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.21203/rs.3.rs-1374739/v1"/></event></pub-history><permissions><copyright-statement>© 2022, Dave et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Dave et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75053-v1.pdf"/><abstract><sec id="abs1"><title>Background:</title><p>Mesenchymal stem cells (MSCs) are multipotent cells that demonstrate therapeutic potential for the treatment of acute and chronic inflammatory-mediated conditions. Although controversial, some studies suggest that MSCs may lose their functionality with cryopreservation which could render them non-efficacious. Hence, we conducted a systematic review of comparative pre-clinical models of inflammation to determine if there are differences in in vivo measures of pre-clinical efficacy (primary outcomes) and in vitro potency (secondary outcomes) between freshly cultured and cryopreserved MSCs.</p></sec><sec id="abs2"><title>Methods:</title><p>A systematic search on OvidMEDLINE, EMBASE, BIOSIS, and Web of Science (until January 13, 2022) was conducted. The primary outcome included measures of in vivo pre-clinical efficacy; secondary outcomes included measures of in vitro MSC potency. Risk of bias was assessed by the SYRCLE ‘Risk of Bias’ assessment tool for pre-clinical studies.</p></sec><sec id="abs3"><title>Results:</title><p>Eighteen studies were included. A total of 257 in vivo pre-clinical efficacy experiments represented 101 distinct outcome measures. Of these outcomes, 2.3% (6/257) were significantly different at the 0.05 level or less; 2 favoured freshly cultured and 4 favoured cryopreserved MSCs. A total of 68 in vitro experiments represented 32 different potency measures; 13% (9/68) of the experiments were significantly different at the 0.05 level or less, with seven experiments favouring freshly cultured MSC and two favouring cryopreserved MSCs.</p></sec><sec id="abs4"><title>Conclusions:</title><p>The majority of preclinical primary in vivo efficacy and secondary in vitro potency outcomes were not significantly different (p&lt;0.05) between freshly cultured and cryopreserved MSCs. Our systematic summary of the current evidence base may provide MSC basic and clinical research scientists additional rationale for considering a cryopreserved MSC product in their pre-clinical studies and clinical trials as well as help identify research gaps and guide future related research.</p></sec><sec id="abs5"><title>Funding:</title><p>Ontario Institute for Regenerative Medicine</p></sec></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cryopreserved</kwd><kwd>mesenchymal stem cells</kwd><kwd>inflammation</kwd><kwd>freshly-cultured</kwd><kwd>systematic review</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008453</institution-id><institution>Ontario Institute for Regenerative Medicine</institution></institution-wrap></funding-source><award-id>2016-0147</award-id><principal-award-recipient><name><surname>Dave</surname><given-names>Chintan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000098</institution-id><institution>Stem Cell Network</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>McIntyre</surname><given-names>Lauralyn</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Administration of cryopreserved as compared freshly cultured MSCs do not appear to negatively impact measures of in vivo efficacy or in vitro potency in animal models of inflammation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mesenchymal stromal cells (mesenchymal stem cells; MSCs) are multipotent stem cells that can be isolated from many adult tissues (e.g. bone marrow, adipose tissue) (<xref ref-type="bibr" rid="bib59">Pittenger et al., 2019</xref>). MSCs have been studied in clinical trials for almost two decades (<xref ref-type="bibr" rid="bib42">Koç et al., 2000</xref>), and have since been implicated in use for diverse conditions (<xref ref-type="bibr" rid="bib27">Gomez-Salazar et al., 2020</xref>). MSCs release growth factors and cytokines along with extracellular vesicles to activate cell proliferation, prevent apoptosis, and ultimately improve regenerative response (<xref ref-type="bibr" rid="bib59">Pittenger et al., 2019</xref>). MSCs may also modulate the immune response by decreasing inflammation, reducing scar formation, increasing pathogen clearance, altering endothelial permeability, and improving mitochondrial dysfunction as demonstrated in different pre-clinical models of inflammation (<xref ref-type="bibr" rid="bib20">Fish and Hajjar, 2015</xref>; <xref ref-type="bibr" rid="bib31">Hoogduijn et al., 2010</xref>; <xref ref-type="bibr" rid="bib29">Gupta et al., 2012</xref>; <xref ref-type="bibr" rid="bib38">Islam et al., 2012</xref>; <xref ref-type="bibr" rid="bib44">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Tsubokawa et al., 2010</xref>). The mechanism for how MSCs modulate inflammation and promote healing is not yet completely understood; however, the observed effect may be mediated by both the direct contact with immune cells and release of soluble factors (<xref ref-type="bibr" rid="bib10">Caplan, 2009</xref>; <xref ref-type="bibr" rid="bib66">Shi et al., 2012</xref>; <xref ref-type="bibr" rid="bib68">Souza-Moreira et al., 2022</xref>). Given their potent immunomodulatory effects, MSCs are particularly attractive for use in infectious as well as acute and chronic inflammatory conditions. There are a growing number of studies that demonstrate the efficacy of MSC therapy in a variety of pre-clinical models, such as acute lung injury (<xref ref-type="bibr" rid="bib11">Chang et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Mei et al., 2007</xref>; <xref ref-type="bibr" rid="bib49">Matthay et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Weiss et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Wilson et al., 2015</xref>), sepsis (<xref ref-type="bibr" rid="bib50">McIntyre et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Mei et al., 2010</xref>), acute myocardial infarction (<xref ref-type="bibr" rid="bib9">Boyle et al., 2010</xref>), multiple sclerosis (<xref ref-type="bibr" rid="bib13">Connick et al., 2011</xref>), graft-versus-host disease (<xref ref-type="bibr" rid="bib6">Baron et al., 2010</xref>; <xref ref-type="bibr" rid="bib37">Introna et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Pérez-Simon et al., 2011</xref>), osteoarthritis (<xref ref-type="bibr" rid="bib19">Emadedin et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Jo et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Orozco et al., 2014</xref>; <xref ref-type="bibr" rid="bib72">Vega et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Vives et al., 2015</xref>), and inflammatory bowel disease (IBD) (<xref ref-type="bibr" rid="bib21">Forbes et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Molendijk et al., 2015</xref>). Moreover, as of March 10, 2022, 1,097 active trials involving MSCs were registered (<ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov">https://www.clinicaltrials.gov</ext-link>). Although MSCs have potential to treat many clinical conditions, a major limitation with nearly all studies is the constrained real-world applicability, where it is vital to have an intervention that is readily available and administered in a time-sensitive manner. For this to occur, the MSCs must overcome the logistical challenges of in-vitro isolation and culture, effective cryopreservation methodology, and a route for rapid accessibility to the bedside. Future real-world therapeutic applications of MSCs will need to be ready for immediate use as off-the-shelf products in urgent medical situations (<xref ref-type="bibr" rid="bib53">Mendicino et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Woods et al., 2016</xref>).</p><p>To date, a majority of preclinical MSC research employ freshly cultured MSCs. In a recent systematic review of the safety of MSCs in 55 randomized clinical trials, only 15 (27%) used cryopreserved cells (<xref ref-type="bibr" rid="bib70">Thompson et al., 2020</xref>), potentially due to the concern that cryopreserved MSCs may lose some of their functionality (<xref ref-type="bibr" rid="bib24">Galipeau et al., 2016</xref>). Some in vitro studies demonstrate a negative impact of cryopreservation on MSC function (<xref ref-type="bibr" rid="bib22">François et al., 2012</xref>; <xref ref-type="bibr" rid="bib12">Chinnadurai et al., 2016</xref>); however, others suggest that cryopreservation may not negatively impact their functionality (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Luetzkendorf et al., 2015</xref>).</p><p>To evaluate evidence currently available in the literature, our team conducted a systematic synthesis of all pre-clinical comparative studies that examined freshly cultured versus cryopreserved MSCs on surrogate measures of in vivo efficacy (primary outcomes) and in vitro potency (secondary outcomes) in animal models of inflammation. The protocol for our systematic review is published in <italic>Systematic Reviews</italic> (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13643-020-01437-z">https://doi.org/10.1186/s13643-020-01437-z</ext-link>) and registered in PROSPERO (CRD42020145833).</p></sec><sec id="s2" sec-type="materials|methods"><title>Materials and methods</title><sec id="s2-1"><title>Search strategy</title><p>We conducted electronic search strategies without language restriction of Ovid platform, Ovid MEDLINE, OvidMEDLINE In-Process &amp; Other Non-Indexed Citations, Embase Classic plus Embase, and BIOSIS and Web of Science using Web of Knowledge until January 13, 2022. Given the non-standard terminology associated with MSCs, several pre-defined terms were used, and the electronic and manual search strategies were developed and tested through an iterative process by an experienced medical information specialist in consultation with the research team (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Six target articles provided by an expert in the field of preclinical research (SM) that were known prior to the search were included in the search criteria to help capture all potential studies. No additional filters were employed to ensure the largest number of relevant studies are captured. We followed the PRISMA guidelines (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) for reporting our systematic review.</p></sec><sec id="s2-2"><title>Assessment of risk of bias</title><p>Risk of bias was assessed independently by two reviewers (CD and AM), and disagreements were resolved via consensus, or by a third reviewer when necessary. All studies were assessed as high, low, or unclear for the 10 domains of bias adapted from the SYRCLE ‘Risk of Bias’ assessment tool for pre-clinical in vivo studies (<xref ref-type="bibr" rid="bib32">Hooijmans et al., 2014</xref>). This tool has been adapted from the Cochrane Collaboration Risk of Bias tool employed in clinical studies, with an aim to incorporate key elements that are relevant for in vivo animal studies. The prompting questions employed to assess risk of bias (AGREE tool) can be found in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. The 10 risk-of-bias domains and signalling questions are provided in Table 7<bold><italic>.</italic></bold></p></sec><sec id="s2-3"><title>Study eligibility</title><p>Pre-clinical studies of in vivo models of inflammation that directly compared freshly cultured to cryopreserved MSC products (randomized, quasi-randomized, and non-randomized designs) were included. To be defined as cryopreserved, MSCs could have been cryopreserved for any duration of time and/or be placed in culture for less than 24 hr post-thaw prior to use in the given experiment. MSCs were considered freshly cultured when the cells were either in continuous culture or cryopreserved but then thawed and placed in culture for at least 24 hr prior to use in experiments. We used this 24-hr culture time as a cut-off as previous experiments suggest that cryopreserved MSCs may require 24 hr of culture to recover their functionality (<xref ref-type="bibr" rid="bib23">Galipeau, 2013</xref>). The study must have included an <italic>animal</italic> model of inflammation where the intervention and comparison groups examined the administration of cryopreserved and freshly cultured MSCs, respectively, delivered by any route, and derived from the same MSC origin (ex. bone marrow, adipose tissue, umbilical cord, or other) and source (xenogeneic, syngeneic, autologous, or allogeneic). MSCs that were pre-treated, pre-conditioned, genetically altered, or co-administered with other experimental interventions were included if the same alteration was applied to both the freshly cultured and cryopreserved MSCs.</p><p>Studies that administered MSCs before or during the induction of the experimental pre-clinical model (i.e. prevention studies) were excluded. We also excluded studies of immunocompromised animals (SCID) or treatments to immunosuppress the animals were excluded because our primary aim was to examine the efficacy of cryopreserved versus freshly cultured MSCs on measures of inflammation in animal models with an intact immune system. Moreover, an intact immune system may be required for MSC immunomodulation via the host cytotoxic cell activity (<xref ref-type="bibr" rid="bib26">Galleu et al., 2017</xref>). Studies that examined the effects of MSCs on implantation and tissue regeneration (e.g. bone regeneration), or compared differentiated MSCs (e.g. differentiated into a myocyte), Mesenchymal Progenitor Cells (MPCs), Mononuclear Cell (MNC) fraction, or stem cells that were not described as MSCs, and studies that only reported in vitro experiments comparing freshly cultured to cryopreserved MSC products were also excluded.</p></sec><sec id="s2-4"><title>Outcomes</title><p>The primary outcomes were surrogate measures of in vivo pre-clinical efficacy that were relevant to specific acute and chronic inflammatory animal models and defined by two outcome domains: 1) The Function and Composition of Tissues (e.g. organ dysfunction, histopathological damage); and 2) Protein Expression and Secretion (e.g. cytokine levels, immunohistochemistry analysis).</p><p>Secondary outcomes included measures of in vitro MSC potency (that were described as additional experiments in the included in vivo studies). Ideally, potency should represent the MSCs’ mechanism of action; however, MSCs have complex and multiple mechanisms of action, all of which are not yet fully characterized or reported (<xref ref-type="bibr" rid="bib24">Galipeau et al., 2016</xref>). In accordance with the International Society for Cellular Therapy perspective paper on this topic (<xref ref-type="bibr" rid="bib24">Galipeau et al., 2016</xref>), MSC potency was based on an assay matrix (collection of assays) that included a combination of in vitro analytical and/or biological assays (e.g. the cellular secretome by ELISA [enzyme-linked immunosorbent assay], or functional cell-based assays [in vitro assay culturing MSCs with responder immune cells] respectively). Hence, the two main secondary in vitro potency outcome domains were: 1) Co-culture assays; and 2) Protein Expression and Secretion (ex: cytokine levels).</p></sec><sec id="s2-5"><title>Study selection and data collection</title><p>The titles and abstracts were screened independently by two members (CD, ED). The full-text of all potentially eligible studies were retrieved and reviewed for eligibility, independently, by two members of the team using the a priori eligibility criteria described above. Disagreements between reviewers were resolved by consensus or by a third member of the systematic review team (LM, SM). Data were extracted independently by two members of the research team into standardized, pilot-tested excel sheet forms (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Authors were contacted for data clarification or for additional data when required.</p></sec><sec id="s2-6"><title>Data analysis</title><p>Meta-analyses were planned as per protocol, if sufficient data were available and if appropriate: two or more studies with similar disease models for an in vivo pre-clinical efficacy outcome, with the same outcome definition. Data reported in non-standard format (e.g. mean ± standard error, median and range) was converted to mean ± standard deviation. Given the complexity and variety of results, the results were summarized in tabular format and presented as number of experiments that reached statistical significance at the 0.05 level.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Search results and study characteristics</title><p>The search strategy yielded 2744 potential studies; and after applying the eligibility criteria and full text review, 18 studies were deemed eligible for inclusion (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Literature search and study inclusion.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75053-fig1-v1.tif"/></fig><p>Eight studies used mice for their experiments (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>), seven studies used rats (<xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>), one study used both mice and rats (<xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>), one study used beagle dogs (<xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>), and one study used guinea pigs (<xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>). Twelve studies included a ’vehicle only’ as an additional control arm (<xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>), while four studies employed a sham animal model, where disease negative animals received MSCs or vehicle (<xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>). One study directly compared cryopreserved and freshly cultured MSCs without an additional control arm (<xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>) and one study employed a sham model, vehicle, and cryopreserved and freshly cultured fibroblasts as controls (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>).</p><p>Of the 18 included studies, seven studied models of preclinical lung injury and sepsis (<xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>), four a wound healing model (<xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>), three of neurological or ocular disease, specifically one of corneal transplantation (<xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>), retinal ischemia/reperfusion (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>), and spinal cord injury model (<xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>), and one each of allergic airway inflammatory disease (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>), wound healing and chronic inflammatory arthritis (<xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>), acute and chronic inflammatory colitis (<xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>), and chronic osteoarthritis (<xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>). Complete reporting of inflammatory models, MSC origins and characteristics can be found in <xref ref-type="table" rid="table1 table2">Tables 1 and 2</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Models of inflammation and characteristics of included studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">First Author (Year)</th><th align="left" valign="bottom">Animal Inflammatory Model</th><th align="left" valign="bottom">Country</th><th align="left" valign="bottom">Language of Publication</th><th align="left" valign="bottom">Species</th><th align="left" valign="bottom">Strain</th><th align="left" valign="bottom">Gender</th><th align="left" valign="bottom">Sample size</th><th align="left" valign="bottom">Age (range)</th><th align="left" valign="bottom">Weight (grams)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref></td><td align="left" valign="bottom">1) Chronic adjuvant-induced arthritis (AIA) model<break/> 2) Hindlimb ischemia model</td><td align="left" valign="bottom">Portugal</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">1) Rat<break/> 2) Mouse</td><td align="left" valign="bottom">1) Winstar<break/> 2) C57BL/6</td><td align="left" valign="bottom">1) Male<break/> 2) Female</td><td align="left" valign="bottom">1) 18<break/> 2) 36</td><td align="left" valign="bottom">1) NR<break/> 2) 12 weeks</td><td align="left" valign="bottom">1) 365–480 g<break/>2) NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref></td><td align="left" valign="bottom">Allergic Airways Inflammation induced by Aspergillus hyphal extract (AHE) exposure in immunocompetent mice</td><td align="left" valign="bottom">USA</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Mouse</td><td align="left" valign="bottom">C57BL/6</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">72</td><td align="left" valign="bottom">8–12 weeks</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref></td><td align="left" valign="bottom">Acute respiratory distress syndrome by intratracheal instillation of <italic>E. coli</italic></td><td align="left" valign="bottom">Canada</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">Sprague-Dawley (specific pathogen-free)</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">350–450 g</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref></td><td align="left" valign="bottom">Acute lung injury induced by <italic>E. coli</italic> pneumonia</td><td align="left" valign="bottom">Ireland</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">Sprague-Dawley (specific pathogen-free)</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">40</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">350–450 g</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref></td><td align="left" valign="bottom">Retinal Ischemia/Reperfusion Injury Model</td><td align="left" valign="bottom">USA</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Mouse</td><td align="left" valign="bottom">C57BL6/J</td><td align="left" valign="bottom">Male and Female</td><td align="left" valign="bottom">37</td><td align="left" valign="bottom">2 months</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref></td><td align="left" valign="bottom">Corneal Transplantation</td><td align="left" valign="bottom">Ireland</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">Lewis</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">8–14 weeks</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref></td><td align="left" valign="bottom">Colitis (3% DSS)</td><td align="left" valign="bottom">Finland</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Mouse</td><td align="left" valign="bottom">Balb/c</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">8 weeks</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td align="left" valign="bottom">Wound healing</td><td align="left" valign="bottom">India</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">Wistar</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">27</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Wound healing</td><td align="left" valign="bottom">India</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Guinea pigs</td><td align="left" valign="bottom">Dunkin Hartley</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">25</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">Ventilator-induced Lung Injury</td><td align="left" valign="bottom">Ireland</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rats</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom"><italic>E. coli</italic>-induced lung injury</td><td align="left" valign="bottom">Ireland</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rats</td><td align="left" valign="bottom">Pathogen-free sprague Dawley</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">300–450 g</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref></td><td align="left" valign="bottom">Spinal Cord Injury induced through a balloon compression method</td><td align="left" valign="bottom">Korea</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Dog</td><td align="left" valign="bottom">Beagle</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">12</td><td align="left" valign="bottom">1.2+/-0.2 years</td><td align="left" valign="bottom">12+/-3 kg</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref></td><td align="left" valign="bottom">Wound healing</td><td align="left" valign="bottom">Ukraine</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Mouse</td><td align="left" valign="bottom">Balb/C</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">27</td><td align="left" valign="bottom">5–6 months</td><td align="left" valign="bottom">25–30 g</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref></td><td align="left" valign="bottom">Polymicrobial sepsis induced by cecal-ligation-and-puncture (CLP)</td><td align="left" valign="bottom">Canada</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Mouse</td><td align="left" valign="bottom">C57BL6/J</td><td align="left" valign="bottom">Female</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">8 weeks</td><td align="left" valign="bottom">17–21 g</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref></td><td align="left" valign="bottom">K.K. pneumoniae induced pneumosepsis</td><td align="left" valign="bottom">Netherlands</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Mouse</td><td align="left" valign="bottom">Pathogen free C57BL/6</td><td align="left" valign="bottom">Female</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">8–10 weeks</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref></td><td align="left" valign="bottom">Wound healing</td><td align="left" valign="bottom">Korea</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">Sprague-Dawley</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">120</td><td align="left" valign="bottom">12 weeks</td><td align="left" valign="bottom">340–360 g</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref></td><td align="left" valign="bottom">Osteoarthritis</td><td align="left" valign="bottom">Japan</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">Wildtype Lewis</td><td align="left" valign="bottom">Female</td><td align="left" valign="bottom">40</td><td align="left" valign="bottom">10 weeks</td><td align="left" valign="bottom">180–200 g</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td align="left" valign="bottom">Ventilator-Induced Lung Injury</td><td align="left" valign="bottom">Ireland</td><td align="left" valign="bottom">English</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">Sprague-Dawley</td><td align="left" valign="bottom">Male</td><td align="left" valign="bottom">28</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">350–450 g</td></tr></tbody></table><table-wrap-foot><fn><p>NR = Not Reported.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>MSC characteristics of included studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">First author (Year)</th><th align="left" valign="bottom" rowspan="2">Species and tissue source</th><th align="left" valign="bottom" rowspan="2">Compatibility with animal</th><th align="left" valign="bottom" rowspan="2">ISCT criteria met</th><th align="left" valign="bottom" rowspan="2">Route of administration</th><th align="left" valign="bottom" rowspan="2">Vehicle</th><th align="left" valign="bottom" rowspan="2">Timing of MSCs post-disease induction</th><th align="left" valign="bottom" colspan="2">Fresh MSCs</th><th align="left" valign="bottom" colspan="3">Cryopreserved MSCs</th></tr><tr><th align="left" valign="bottom">Cryopreserved at any point?</th><th align="left" valign="bottom">Duration of culture</th><th align="left" valign="bottom">Method</th><th align="left" valign="bottom">Duration</th><th align="left" valign="bottom">Time from Thaw to Experiment</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref></td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">1) Intra-articular<break/>2) Intra-muscular</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">1) 7 days<break/>2) 5 hr</td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">&gt;5 days</td><td align="left" valign="bottom">Controlled Rate Freezer</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Immediately</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref></td><td align="left" valign="bottom">Human and Murine Bone Marrow</td><td align="left" valign="bottom">Syngenic and Xenogenic</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">14 days</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">-–80°C for 48 hr then liquid nitrogen</td><td align="char" char="." valign="bottom">9 days</td><td align="char" char="." valign="bottom">15 min</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref></td><td align="left" valign="bottom">Human Umbilical Cord and Bone Marrow</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">4 days</td><td align="left" valign="bottom">Controlled Rate Freezer</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Day of administration</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref></td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">0.5 hr</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="char" char="." valign="bottom">30 min</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref></td><td align="left" valign="bottom">Human</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Intra-ocular</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">2 hr</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">&gt;7 days</td><td align="left" valign="bottom">Controlled Rate Freezer</td><td align="char" char="ndash" valign="bottom">7–30 days</td><td align="char" char="." valign="bottom">&lt;1 hr</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref></td><td align="left" valign="bottom">Rat Bone Marrow</td><td align="left" valign="bottom">Allogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">1 and 7 days prior</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">–80°C for 24 hr then liquid nitrogen</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Immediately</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref></td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">0.9% NaCl +3.6% HAS</td><td align="left" valign="bottom">3 and 5 days</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td align="left" valign="bottom">Gravid caprine AF (amniotic fluid), AS (amniotic sac), WJ (Wharton's jelly), CB (cord blood)</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Subcutaneously</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">7, 14, 21, 28 days</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">–80°C overnight then liquid nitrogen</td><td align="left" valign="bottom">Atleast 1 month</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Surgically placed over wound</td><td align="left" valign="bottom">Polypropylene mesh</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">–80°C overnight then liquid nitrogen</td><td align="char" char="." valign="bottom">1 month</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">6 hr</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">Human Bone Marrow and Umbilical Cord</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intra-tracheal</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">30 min</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Immediately</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref></td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">Allogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">Hartmann’s Solution</td><td align="left" valign="bottom">Immediately</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">4 °C for 1 hr, –20 °C for 2 hr, –80 °C for 24 hr, then –150 °C</td><td align="char" char="ndash" valign="bottom">2–3 weeks</td><td align="left" valign="bottom">Immediately</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref></td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Implantation into wound</td><td align="char" char="." valign="bottom">3D gel</td><td align="left" valign="bottom">Immediately</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">–80°C the liquid nitrogen</td><td align="char" char="." valign="bottom">1 month</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref></td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">5% Human Albumin in PlasmaLyte</td><td align="left" valign="bottom">6 hr</td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">&gt;24 hr</td><td align="left" valign="bottom">Controlled Rate Freezer</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Immediately</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref></td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">Ringer’s Lactate</td><td align="left" valign="bottom">1 or 6 hr</td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">24 hr</td><td align="left" valign="bottom">Liquid nitrogen</td><td align="left" valign="bottom">Until required</td><td align="left" valign="bottom">Day of administration</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref></td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intratendinous</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Immediately</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">–80°C then –196 °C Liquid Nitrogen</td><td align="left" valign="bottom">Up to 1 month</td><td align="left" valign="bottom">Immediately</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref></td><td align="left" valign="bottom">Rat Synovial Fluid</td><td align="left" valign="bottom">Allogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intraarticular</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Every week from 2 to 8 weeks</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">7 days</td><td align="left" valign="bottom">–80 °C overnight, and then at –150 °C</td><td align="char" char="." valign="bottom">16 months</td><td align="left" valign="bottom">Immediately</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">Xenogenic</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Intravenous</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">15 min</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Up to 2 months</td><td align="left" valign="bottom">Immediately</td></tr></tbody></table></table-wrap></sec><sec id="s3-2"><title>Description of cryopreservation and thaw process for cryopreserved MSCs</title><p>The duration of cryopreservation for cryopreserved MSCs prior to use in experiments was not reported in nine studies (<xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>), four studies cryopreserved the MSCs for at least 1 month (<xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>), and two for up to 2 months (<xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>). One study cryopreserved MSCs for 2–3 weeks (<xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>), another between 1 and 4 weeks (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>), and one study cryopreserved their MSCs for 9 days (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>).</p><p>Ten studies used 10% DMSO (dimethyl sulfoxide) as part of their cryopreservation solution (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>), three studies used CryoStor Cell Preservation Media (Sigma-Aldrich) (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>), one study used MSC Freezing media (Biological Industries) (<xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>), one study used 5% DMSO (<xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>), and three studies did not report the solution used for cryopreservation (<xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>). Five studies did not report on their method of cryopreservation (<xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>), three studies employed a controlled-rate freezer to achieve cryopreservation (<xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>), while eight studies used liquid nitrogen at –80°C to –196°C (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>) for storage, and two studies gradually cryopreserved the MSCs with decremental temperature over 24 hr, followed by storage at –150 °C (<xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>).</p><p>Eight studies did not report their thawing protocol (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>), one study employed a cell-thawing device called the ThawStar (AsteroBio, USA) (<xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>) and the remaining nine studies used a 37 °C hot water bath to thaw the cryopreserved MSCs (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>). Two studies thawed MSCs on the day of administration for their experiments (<xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>), while nine studies reported thawing MSCs either immediately or within 1 hr of use in experimentation (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>). Seven studies did not report time from thaw to use in experimentation (<xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>). Nine studies suspended thawed MSCs in phosphate buffered saline (PBS, vehicle for experiments) (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>), while one study re-suspended them in ringer’s lactate supplemented with 3% Dimethyl sulfoxide (DMSO) (<xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>), one used MSCs suspended in 0.9% NaCl +3.6% HSA (Human Serum Albumin) (<xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>), one used PBS with 5% HSA (<xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>), and six studies did not report their resuspension solution (<xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>).</p></sec><sec id="s3-3"><title>Description of cryopreservation and culture process for freshly cultured MSCs</title><p>Freshly cultured MSCs were not cryopreserved at any point after harvest from source in 13 studies (range of total culture time: 4–28 days) (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>). In five studies, the MSCs were cryopreserved and then culture-expanded for more than 24 hr prior to use in experimentation (<xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>).</p><p>Further details related to MSC culture, including medium, passage, concentration, and route of administration can be found in <xref ref-type="table" rid="table2">Table 2</xref>.</p></sec><sec id="s3-4"><title>Risk of bias</title><p>Of the 18 included studies, none of them met low-risk of bias criteria for all 10 domains and all studies demonstrated unclear risk of bias due to lack or reporting in atleast two domains. Ten studies did not have any features that would confer a high-risk of bias in the one of the 10 domains (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>). Five studies demonstrated high-risk of bias in one domain (<xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>), and the remaining three studies demonstrated high-risk of bias in two or more domains (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>). The complete reporting of the risk of bias domains is presented in <xref ref-type="table" rid="table3">Table 3</xref>.</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Risk of Bias assessments for the included in vivo studies using SYRCLE Tool.</title></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="4" style="author-callout-style-b2"><italic>Selection Bias</italic></td><td colspan="2" style="author-callout-style-b2"><italic>Performance Bias</italic></td><td colspan="2" style="author-callout-style-b2"><italic>Detection Bias</italic></td><td style="author-callout-style-b2"><italic>Attrition Bias</italic></td><td style="author-callout-style-b2"><italic>Reporting Bias</italic></td><td style="author-callout-style-b2"><italic>Other Bias</italic></td></tr><tr><td style="author-callout-style-b1"><bold>Author (year)</bold></td><td style="author-callout-style-b1"><bold>Adequate randomization</bold></td><td style="author-callout-style-b1"><bold>Baseline charactersics given</bold></td><td style="author-callout-style-b1"><bold>Evidence of adequate concealment of groups</bold></td><td style="author-callout-style-b1"><bold>Evidence of random housing of animals</bold></td><td style="author-callout-style-b1"><bold>Evidence of caregivers blinded to intervention</bold></td><td style="author-callout-style-b1"><bold>Evidence of random selection for assessment</bold></td><td style="author-callout-style-b1"><bold>Evidence of assessor blinded</bold></td><td style="author-callout-style-b1"><bold>Explanation of missing animal data</bold></td><td style="author-callout-style-b1"><bold>Free of selective reporting based on methods/results</bold></td><td style="author-callout-style-b1"><bold>Free of other high bias risk</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b7">No (High Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref></td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b7">No (High Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref></td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref></td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b7">No (High Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref></td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td style="author-callout-style-b7">No (High Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref></td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr><tr><td style="author-callout-style-b8"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b3">Unclear</td><td style="author-callout-style-b2">Yes (Low Risk)</td><td style="author-callout-style-b2">Yes (Low Risk)</td></tr></tbody></table></table-wrap></sec><sec id="s3-5"><title>Primary and secondary outcomes</title><p>Across the 18 included studies, a total of 325 experiments and 133 distinct outcome measures were reported on our primary and secondary outcomes and are summarized below. Data extraction of outcomes from included studies yielded significant amounts of data given the extensive and varied inflammatory disease models and their specific outcomes. A description of all primary in vivo pre-clinical efficacy and secondary in vitro potency outcomes are reported in <xref ref-type="table" rid="table4">Table 4</xref> and 6, respectively. The studies included in our systematic review varied with respect to disease type, MSC source, MSC processing, route of administration, dose, outcome measures, and timing of outcome measurement. Due to this high degree of heterogeneity, meta-analyses were not feasible for the primary and secondary outcome measures. However, similar pre-clinical animal inflammatory models that reported similar outcomes are reported in <xref ref-type="table" rid="table5">Table 5</xref> for reference.</p><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>All in vivo outcomes where freshly cultured vs. cryopreserved MSCs have been compared directly are reported.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Study</th><th align="left" valign="bottom">Animal Model</th><th align="left" valign="bottom">Outcome</th><th align="left" valign="bottom">Number (n)</th><th align="left" valign="bottom">Type and Source of MSCs</th><th align="left" valign="bottom">Duration of Culture Post-Thaw (hr)</th><th align="left" valign="bottom">Concentration of MSCs</th><th align="left" valign="bottom">Pre-Treatment of MSCs</th><th align="left" valign="bottom">Negative Control (NC)</th><th align="left" valign="bottom">Positive Control (PC)</th><th align="left" valign="bottom">p-value for Fresh MSCs vs. control</th><th align="left" valign="bottom">p-value for Frozen MSCs vs. control</th><th align="left" valign="bottom">Fresh or Frozen MSC more effective?</th><th align="left" valign="bottom">p-value for Fresh vs. Frozen comparison</th></tr></thead><tbody><tr><td align="left" valign="bottom" colspan="14"><bold>Acute Lung Injury and Sepsis</bold></td></tr><tr><td align="left" valign="bottom" rowspan="7"><xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref></td><td align="left" valign="bottom" rowspan="7">Acute lung injury induced by <italic>E. coli</italic> pneumonia in rats</td><td align="left" valign="bottom">Arterial oxygenation</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 hMSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Lung compliance</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 hMSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">BAL protein</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 hMSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">BAL neutrophils</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 hMSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">BAL <italic>E. coli</italic> bacterial load</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 hMSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">BAL IL-6</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 hMSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">BAL IL-10</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 hMSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref></td><td align="left" valign="bottom">Allergic Airways Inflammation induced by Aspergillus hyphal extract (AHE) exposure in mice.</td><td align="left" valign="bottom">Large Airway Resistance</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Large Airway Resistance</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Overall Tissue Resistance</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Overall Tissue Resistance</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Elastance</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Elastance</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Inflammation Score</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Inflammation Score</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BALF Total Cell Number</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BALF Total Cell Number</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Neutrophils</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Neutrophils</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Eosinophils</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Eosinophils</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Macrophages</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Macrophages</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Lymphocytes</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Lymphocytes</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">Frozen better</td><td align="left" valign="bottom"><bold>&lt;0.05</bold></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-1a</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-1a</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-3</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-3</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-4</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-4</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-5</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-5</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-6</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-6</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-10</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-10</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-12-p40</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-12-p40</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-13</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-13</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-17</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><bold>&lt;0.05</bold></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-17</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL KC</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><bold>&lt;0.05</bold></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL KC</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">Frozen better</td><td align="left" valign="bottom"><bold>&lt;0.05</bold></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL RANTES</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL RANTES</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">IFN-y</td><td align="left" valign="bottom">10 (Fresh) and 7 (Frozen)</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">IFN-y</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Murine Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 × 10^6 viable MSC cells</td><td align="left" valign="bottom">Frozen MSCs washed 3 times prior to use</td><td align="left" valign="bottom">Naïve (PBS model)</td><td align="left" valign="bottom">AHE +PBS,<break/>Human Lung Fibroblasts</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref></td><td align="left" valign="bottom">Acute respiratory distress syndrome by intratracheal instillation of <italic>E. coli</italic> in rats.</td><td align="left" valign="bottom">Arterial Oxygenation (FiO2=0.3)</td><td align="left" valign="bottom">8–10</td><td align="left" valign="bottom">Human Umbilical Cord (Frozen) and Bone marrow (Fresh) MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom"><italic>E. coli</italic>+PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Arterial Oxygenation (FiO2=1)</td><td align="left" valign="bottom">8–10</td><td align="left" valign="bottom">Human Umbilical Cord (Frozen) and Bone marrow (Fresh) MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom"><italic>E. coli</italic>+PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Compliance</td><td align="left" valign="bottom">8–10</td><td align="left" valign="bottom">Human Umbilical Cord (Frozen) and Bone marrow (Fresh) MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom"><italic>E. coli</italic>+PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wet:Dry Lung Ratio</td><td align="left" valign="bottom">8–10</td><td align="left" valign="bottom">Human Umbilical Cord (Frozen) and Bone marrow (Fresh) MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom"><italic>E. coli</italic>+PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Neutrophils</td><td align="left" valign="bottom">8–10</td><td align="left" valign="bottom">Human Umbilical Cord (Frozen) and Bone marrow (Fresh) MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom"><italic>E. coli</italic>+PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Bacteria</td><td align="left" valign="bottom">8–10</td><td align="left" valign="bottom">Human Umbilical Cord (Frozen) and Bone marrow (Fresh) MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom"><italic>E. coli</italic>+PBS</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref></td><td align="left" valign="bottom">1) Chronic adjuvant-induced arthritis (AIA) model<break/>2) Hindlimb ischemia model in mice</td><td align="left" valign="bottom">Arthritis Index</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1.7×10^6 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Left Paw Volume</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1.7×10^6 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Right Paw Volume</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1.7×10^6 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Weight</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1.7×10^6 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">Sham model +PBS</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Blood Flow Ratio in Hindlimb D0</td><td align="left" valign="bottom">12</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2×10^5 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Blood Flow Ratio in Hindlimb D7</td><td align="left" valign="bottom">12</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2×10^5 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>=0.008</td><td align="left" valign="bottom"><italic>P</italic>=0.019</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Blood Flow Ratio in Hindlimb D14</td><td align="left" valign="bottom">12</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2×10^5 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>=0.012</td><td align="left" valign="bottom"><italic>P</italic>=0.031</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Blood Flow Ratio in Hindlimb D21</td><td align="left" valign="bottom">12</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2×10^5 MSCs</td><td align="left" valign="bottom">Fresh MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>=0.004</td><td align="left" valign="bottom"><italic>P</italic>=0.002</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref></td><td align="left" valign="bottom">Acute phase and Regenerative Phase of Colitis model in mice</td><td align="left" valign="bottom">Macroscopic Score</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Colon Weight (% change)</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS<break/>NC = <italic>P</italic>=0.001</td><td align="left" valign="bottom">PC: NS<break/>NC: <italic>P</italic>=0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Colon Length</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS<break/>NC = <italic>P</italic>=0.018</td><td align="left" valign="bottom">PC: NS<break/>NC: <italic>P</italic>=0.014</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Histopathology Scpre</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS<break/>NC = <italic>P</italic>=0.004</td><td align="left" valign="bottom">PC: NS<break/>NC: <italic>P</italic>=0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Regeneration</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">IL-1b in colon tissue homogenates</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">TNFa in colon tissue homogenates</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">IL-1b mRNA in colon</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Corticosterone in colon tissue homogenates</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Tissue ACE levels</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Atgr1a mRNA expression</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">ACE shedding</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">0.5 x<break/>10^6 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model with PBS</td><td align="left" valign="bottom">Colitis +Vehicle</td><td align="left" valign="bottom">PC: NS</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td align="left" valign="bottom">Wound Healing of surgical dorsal limb wound in rats</td><td align="left" valign="bottom">Wound Area D0</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Epithelization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Neovascularization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Thickness</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Density</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Fluid</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D0</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Epithelization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Neovascularization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Thickness</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Density</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Amniotic Sac</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D0</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Epithelization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Neovascularization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Thickness</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Density</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Wharton’s Jelly</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D0</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wound Area D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D7</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D14</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D21</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Wound Contraction D28</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Epithelization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Neovascularization</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Thickness</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Density</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Caprine Cord Blood</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">Frozen better</td><td align="left" valign="bottom"><bold><italic>P</italic>&lt;0.05</bold></td></tr><tr><td align="left" valign="bottom" rowspan="2"><xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref></td><td align="left" valign="bottom" rowspan="2">Corneal Transplantation in rats</td><td align="left" valign="bottom">Opacity Score, measured from day 5 post-implantation to day 30</td><td align="left" valign="bottom">Fresh = 13,<break/>Frozen = 10</td><td align="left" valign="bottom">Rat Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 MSC</td><td align="left" valign="bottom">Frozen MSCs pre-treated with allogenic splenocytes, and co-intervention with MMF.<break/>No MMF for Fresh MSCs.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Transplantation +No treatment</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom">Neovascularization Score, measured from day 5 post-implantation to day 30</td><td align="left" valign="bottom">Fresh = 13,<break/>Frozen = 10</td><td align="left" valign="bottom">Rat Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 MSC</td><td align="left" valign="bottom">Frozen MSCs pre-treated with allogenic splenocytes, and co-intervention with MMF.<break/>No MMF for Fresh MSCs.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Transplantation +No treatment</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref></td><td align="left" valign="bottom">Retinal ischemia/reperfusion model in mice</td><td align="left" valign="bottom">Retinal ganglion cells/mm^2</td><td align="left" valign="bottom">Fresh = 10,<break/>Frozen = 8</td><td align="left" valign="bottom">Human MSCs</td><td align="left" valign="bottom">&lt;1 hr</td><td align="left" valign="bottom">3×10^4 MSC</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>=0.019</td><td align="left" valign="bottom"><italic>P</italic>=0.024</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref></td><td align="left" valign="bottom">Pneumosepsis Caused by Klebsiella<break/>pneumoniae</td><td align="left" valign="bottom">Lung Bacterial Load at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Bacterial Load at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Blood Bacterial Load at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Blood Bacterial Load at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Liver Bacterial Load at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Liver Bacterial Load at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Spleen Bacterial Load at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Spleen Bacterial Load at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung TNFa at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung TNFa at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung IL-1b at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung IL-1b at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung IL-6 at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung IL-6 at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">MIP-2 at 16 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">MIP-2 at 48 hours</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^6 ASCs</td><td align="left" valign="bottom">MSCs infused at 1 or 6 hours<break/>after infection.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom"><italic>E. coli</italic>-induced lung injury.</td><td align="left" valign="bottom">Arterial Oxygenation</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Wet:Dry Ratio</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Compliance</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL <italic>E. coli</italic> Counts</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL WCC levels</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Neutrophils</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-1b</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL CINC-1</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-6</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1 ×<break/>10^7 MSCs/kg</td><td align="left" valign="bottom">Isolated CD362+MSCs for use</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">Ventilator-induced Lung Injury</td><td align="left" valign="bottom">Arterial Oxygenation</td><td align="left" valign="bottom">Fresh, n=7–8; Cryopreserved, n=5–<break/>6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Compliance</td><td align="left" valign="bottom">Fresh, n=7–8; Cryopreserved, n=5–<break/>6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Lung Wet:Dry Ratio</td><td align="left" valign="bottom">Fresh, n=7–8; Cryopreserved, n=5–<break/>6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Protein</td><td align="left" valign="bottom">Fresh, n=7–8; Cryopreserved, n=5–<break/>6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Percentage of Alveolar Airspace</td><td align="left" valign="bottom">Fresh, n=8;<break/>Cryopreserved, n=6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Neutrophils</td><td align="left" valign="bottom">Fresh, n=6–8;<break/>Cryopreserved, n=5–6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL CINC-1</td><td align="left" valign="bottom">Fresh, n=6–8;<break/>Cryopreserved, n=5–6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-6</td><td align="left" valign="bottom">Fresh, n=6–8;<break/>Cryopreserved, n=5–6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-10</td><td align="left" valign="bottom">Fresh, n=6–8;<break/>Cryopreserved, n=5–6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL KGF</td><td align="left" valign="bottom">Fresh, n=6–8;<break/>Cryopreserved, n=5–6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL PGE2</td><td align="left" valign="bottom">Fresh, n=6–8;<break/>Cryopreserved, n=5–6</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^7 MSCs/<break/>kg</td><td align="left" valign="bottom">Pre-activated MSCs (fresh and frozen were also used)</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref></td><td align="left" valign="bottom">Polymicrobial sepsis induced by cecal-ligation-and-puncture (CLP)</td><td align="left" valign="bottom">%CD11b+/<italic>E. coli</italic>+cells in Peritoneal Fluid</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Peritoneal CFU #</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasma Lactate</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasma CCL5</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasma JE</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasma KC</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasma LIX</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasma IL-10</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasma IL-1b</td><td align="left" valign="bottom">Fresh, n=12;<break/>Cryopreserved, n=11</td><td align="left" valign="bottom">Human Bone Marrow</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">2.5×10^5 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Sham model</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Wound healing model with 2×2 cm^2<break/>full-thickness excision skin wound in guinea pigs</td><td align="left" valign="bottom">Percent wound contraction D7</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Percent wound contraction D14</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Percent wound contraction D21</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Percent wound contraction D28</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Epithelialization</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Neovascularization</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Density</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen Thickness</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Dog Bone Marrow</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">MSCs attached to polypropylene mesh of 2×2 cm2 size</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Antibiotic only, Mesh only, and MSCs only as control groups</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref></td><td align="left" valign="bottom">Wound Healing of<break/>Full-thickness excisional skin wounds in mice</td><td align="left" valign="bottom">Percent Wound Closure D3</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">24 hours</td><td align="left" valign="bottom">0.25‐0.3×10^6 cells in 50 μl</td><td align="left" valign="bottom">MSCs placed on 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Spontaneous healing, and 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO alone</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Percent Wound Closure D7</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">24 hours</td><td align="left" valign="bottom">0.25‐0.3×10^6 cells in 50 μl</td><td align="left" valign="bottom">MSCs placed on 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Spontaneous healing, and 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO alone</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Percent Wound Closure D14</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">24 hours</td><td align="left" valign="bottom">0.25‐0.3×10^6 cells in 50 μl</td><td align="left" valign="bottom">MSCs placed on 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Spontaneous healing, and 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO alone</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Percent Wound Closure D28</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">Human Adipose Tissue</td><td align="left" valign="bottom">24 hours</td><td align="left" valign="bottom">0.25‐0.3×10^6 cells in 50 μl</td><td align="left" valign="bottom">MSCs placed on 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Spontaneous healing, and 3D gel containing PPP, 0.2 M<break/>sucrose, 1% DMSO alone</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref></td><td align="left" valign="bottom">Acute Spinal Cord Injury in dogs</td><td align="left" valign="bottom">Motor activity of hind limbs<break/>assessed by using the canine Basso Beattie Bresnahan (cBBB)<break/>score at Week 1</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 MSC cells</td><td align="left" valign="bottom">Lentivirus Mediated HO-1 Gene Insertion into Ad-<break/>MSCs.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh MSCs expressing GFP only.</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">cBBB score at Week 2</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 MSC cells</td><td align="left" valign="bottom">Lentivirus Mediated HO-1 Gene Insertion into Ad-<break/>MSCs.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh MSCs expressing GFP only.</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">cBBB score at Week 3</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 MSC cells</td><td align="left" valign="bottom">Lentivirus Mediated HO-1 Gene Insertion into Ad-<break/>MSCs.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh MSCs expressing GFP only.</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">cBBB score at Week 4</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 MSC cells</td><td align="left" valign="bottom">Lentivirus Mediated HO-1 Gene Insertion into Ad-<break/>MSCs.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh MSCs expressing GFP only.</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% age of gross lesion area</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 MSC cells</td><td align="left" valign="bottom">Lentivirus Mediated HO-1 Gene Insertion into Ad-<break/>MSCs.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh MSCs expressing GFP only.</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Fibrotic areas relative to normal</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 MSC cells</td><td align="left" valign="bottom">Lentivirus Mediated HO-1 Gene Insertion into Ad-<break/>MSCs.</td><td align="left" valign="bottom">Normal (no SCI)</td><td align="left" valign="bottom">Fresh MSCs expressing GFP only.</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Myelinated areas relative to normal</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Dog Adipose Tissue</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">1×10^7 MSC cells</td><td align="left" valign="bottom">Lentivirus Mediated HO-1 Gene Insertion into Ad-<break/>MSCs.</td><td align="left" valign="bottom">Normal (no SCI)</td><td align="left" valign="bottom">Fresh MSCs expressing GFP only.</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref></td><td align="left" valign="bottom">Wound healing in rats</td><td align="left" valign="bottom">Total macroscopic score at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>=0.001</td><td align="left" valign="bottom"><italic>P</italic>=0.04</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Total macroscopic score at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>=0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Total degeneration score at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Total degeneration score at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Fibre structure at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Fibre structure at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Fibre arrangement at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Fibre arrangement at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Rounding of nuclei at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Rounding of nuclei at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Variations in cellularity at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Variations in cellularity at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Decreased stainability at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Decreased stainability at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Hyalinization at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Hyalinization at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Inflammation at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Inflammation at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Fibroblast density at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Fibroblast density at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Nuclear aspect ratio at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Nuclear aspect ration at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Nuclear orientation at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Nuclear orientation at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen organization at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen organization at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen fibre coherence at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Collagen fibre coherence at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">GAG-rich area at 2 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">GAG-rich area at 4 weeks</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Ultimate failure load at 2 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Ultimate failure load at 4 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Tendon stiffness at 2 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Tendon stiffness at 4 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Ultimate stress at 2 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Ultimate stress at 4 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Cross-sectional area at 2 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Cross-sectional area at 4 weeks</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cryoprotectant and PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom" rowspan="5"><xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref></td><td align="left" valign="bottom" rowspan="5">Osteoarthritis model in rats</td><td align="left" valign="bottom">Bioluminescence</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Rat synovial MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Tibia gross finding score</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Rat synovial MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Femur gross finding score</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Rat synovial MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Tibia OARSI score</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Rat synovial MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Femur OARSI score</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Rat synovial MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1×10^6 MSC cells</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh-MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td align="left" valign="bottom">Ventilator-Induced Lung Injury (VILI) model in rats</td><td align="left" valign="bottom">Arterial oxygenation</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Static Lung Compliance</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Wet:Dry Ratio</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Protein</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Cell count</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL Neutrophil count</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-6 level</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">Frozen better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">BAL IL-1 level</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">% Airspace</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">1 × 10^7 MSCs/kg</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">PBS</td><td align="left" valign="bottom">Fresh MSCs</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr></tbody></table><table-wrap-foot><fn><p>↔ indicates no statistically significant difference of Freshly-cultured and Cryopreserved MSCs.</p></fn><fn><p>NS indicates Not Significant- statistical analysis from individual studies did not yield significant difference between Freshly-cultured and Cryopreserved MSCs. NR = Not reported.</p></fn><fn><p>If direct comparison of Freshly-cultured vs. Cryopreserved MSC was not presented in the same graph by a study, the results and discussion sections of that study were used to judge efficacy of Freshly-cultured vs. Cryopreserved MSCs for the table above.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table5" position="float"><label>Table 5.</label><caption><title>Summary of similar in-vivo outcomes reported across studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Outcome Measure</th><th align="left" valign="bottom">Study</th><th align="left" valign="bottom">Unit of Measurement</th><th align="left" valign="bottom">Number of samples (n)</th><th align="left" valign="bottom">Fresh MSC Mean</th><th align="left" valign="bottom">Fresh MSC Std Dev</th><th align="left" valign="bottom">Frozen MSC Mean</th><th align="left" valign="bottom">Frozen MSC Std Dev</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="4"><bold>Arterial Oxygenation0.128</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref></td><td align="left" valign="bottom">mmHg</td><td align="char" char="." valign="bottom">8 to 10</td><td align="left" valign="bottom">217.77</td><td align="left" valign="bottom">77.93</td><td align="left" valign="bottom">242.75</td><td align="left" valign="bottom">84.14</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref></td><td align="left" valign="bottom">mmHg</td><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">265.5</td><td align="left" valign="bottom">67.86</td><td align="left" valign="bottom">247.64</td><td align="left" valign="bottom">68.232</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">mmHg</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">73.084</td><td align="left" valign="bottom">11.526</td><td align="left" valign="bottom">69.148</td><td align="left" valign="bottom">9.222</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td align="left" valign="bottom">kPa</td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">16.52</td><td align="left" valign="bottom">0.85</td><td align="left" valign="bottom">16.86</td><td align="left" valign="bottom">1.10</td></tr><tr><td align="left" valign="bottom" rowspan="4"><bold>Lung Compliance</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref></td><td align="left" valign="bottom">mL/mmHg</td><td align="char" char="." valign="bottom">8 to 10</td><td align="left" valign="bottom">0.862</td><td align="left" valign="bottom">0.082</td><td align="left" valign="bottom">0.818</td><td align="left" valign="bottom">0.098</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref></td><td align="left" valign="bottom">mL/mmHg</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">0.82264</td><td align="left" valign="bottom">0.132</td><td align="left" valign="bottom">0.765</td><td align="left" valign="bottom">0.128</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">mL/mmHg</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">0.55939</td><td align="left" valign="bottom">0.089</td><td align="left" valign="bottom">0.451</td><td align="left" valign="bottom">0.531</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td align="left" valign="bottom">mL/cmH2O</td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">0.363</td><td align="left" valign="bottom">0.06</td><td align="left" valign="bottom">0.358</td><td align="left" valign="bottom">0.08</td></tr><tr><td align="left" valign="bottom" rowspan="3"><bold>Wet:Dry Lung Ratio</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref></td><td align="left" valign="bottom">Ratio</td><td align="char" char="." valign="bottom">8 to 10</td><td align="left" valign="bottom">4.72779</td><td align="left" valign="bottom">0.188</td><td align="left" valign="bottom">4.77</td><td align="left" valign="bottom">0.157</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">Ratio</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">4.7643</td><td align="left" valign="bottom">0.074</td><td align="left" valign="bottom">4.94</td><td align="left" valign="bottom">0.294</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td align="left" valign="bottom">Ratio</td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">5.21</td><td align="left" valign="bottom">0.36</td><td align="left" valign="bottom">5.32</td><td align="left" valign="bottom">0.42</td></tr><tr><td align="left" valign="bottom" rowspan="3"><bold>BAL IL-6 levels</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref></td><td align="left" valign="bottom">pg/ml</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">348.93</td><td align="left" valign="bottom">207.5</td><td align="left" valign="bottom">363.22</td><td align="left" valign="bottom">142.5</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref></td><td align="left" valign="bottom">pg/ml</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">224.67</td><td align="left" valign="bottom">119.86</td><td align="left" valign="bottom">181.51</td><td align="left" valign="bottom">126.72</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref></td><td align="left" valign="bottom">pg/ml</td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">252.39</td><td align="left" valign="bottom">61.64</td><td align="left" valign="bottom">207.76</td><td align="left" valign="bottom">53.66</td></tr><tr><td align="left" valign="bottom" rowspan="3"><bold>% of Wound Contraction on D7</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">60.076</td><td align="left" valign="bottom">16.67</td><td align="left" valign="bottom">55.679</td><td align="left" valign="bottom">12.755</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">16.104</td><td align="left" valign="bottom">1.062</td><td align="left" valign="bottom">14.521</td><td align="left" valign="bottom">2.123</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">14</td><td align="left" valign="bottom">51.402</td><td align="left" valign="bottom">5.741</td><td align="left" valign="bottom">52.069</td><td align="left" valign="bottom">4.94</td></tr><tr><td align="left" valign="bottom" rowspan="3"><bold>% of Wound Contraction on D14</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">96.374</td><td align="left" valign="bottom">0.85</td><td align="left" valign="bottom">89.937</td><td align="left" valign="bottom">5.103</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">67.363</td><td align="left" valign="bottom">1.69</td><td align="left" valign="bottom">71.537</td><td align="left" valign="bottom">2.123</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">14</td><td align="left" valign="bottom">99.065</td><td align="left" valign="bottom">2.8</td><td align="left" valign="bottom">99.866</td><td align="left" valign="bottom">2.804</td></tr><tr><td align="left" valign="bottom" rowspan="2"><bold>% of Wound Contraction on D21</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">99.85</td><td align="left" valign="bottom">0.681</td><td align="left" valign="bottom">98.515</td><td align="left" valign="bottom">2.89</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">84.141</td><td align="left" valign="bottom">1.93</td><td align="left" valign="bottom">89.457</td><td align="left" valign="bottom">1.769</td></tr><tr><td align="left" valign="bottom" rowspan="2"><bold>% of Wound Contraction on D28</bold></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">100.433</td><td align="left" valign="bottom"/><td align="left" valign="bottom">100.288</td><td align="left" valign="bottom">0.681</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Percentage</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">99.583</td><td align="left" valign="bottom">0.885</td><td align="left" valign="bottom">99.415</td><td align="left" valign="bottom">0.885</td></tr></tbody></table></table-wrap></sec><sec id="s3-6"><title>Primary outcomes</title><sec id="s3-6-1"><title>In vivo pre-clinical efficacy outcomes</title><p>The 18 studies reported a total of 257 experiments and 101 distinct outcome measures related to our in vivo pre-clinical efficacy primary outcomes. Seventeen studies assessed composition of tissues (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>), and 12 assessed organ dysfunction (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>). Eleven of the 18 studies assessed protein expression and secretion (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Salmenkari et al., 2019</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>) (<xref ref-type="table" rid="table2">Table 2</xref>)<bold>.</bold></p><p>Of the 257 experiments, six outcomes were significantly different at the 0.05 level or less, with two that favoured freshly cultured and four that favoured cryopreserved MSCs (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s3-6-2"><title>In vivo pre-clinical efficacy: function and composition of tissue</title><p>Seventeen studies reported organ dysfunction and/or composition of tissue outcomes and a total of 166 experiments were reported across the studies. Of the 116 experiments, only one reported a significant difference at the 0.05 level or less between the freshly cultured and cryopreserved MSC groups which favoured the cryopreserved group (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Primary in vivo outcomes.</title><p>All the outcomes related to function and composition of tissues are presented below. Number of experiments represent the number of separate comparisons between freshly cultured and cryopreserved MSCs on surrogate measures of in vivo efficacy.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75053-fig2-v1.tif"/></fig></sec><sec id="s3-6-3"><title>In vivo pre-clinical efficacy: protein (cytokine) expression and secretion</title><p>Eleven studies reported protein expression and secretion outcomes, with total of 91 experiments reported across the studies. Five of the 91 experiments reported a statistically significant difference between freshly cultured and cryopreserved MSCs that were derived from one study (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>). Of the five experiments that demonstrated a significant difference at the 0.05 level or less, two favoured freshly cultured and three favoured cryopreserved MSCs (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Primary in-vivo outcomes.</title><p>All the outcomes related to protein (cytokine) expression and secretion are presented below. Number of experiments represent the number of separate comparisons between freshly cultured and cryopreserved MSCs on surrogate measures of in vivo efficacy.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75053-fig3-v1.tif"/></fig></sec></sec><sec id="s3-7"><title>Secondary outcomes</title><sec id="s3-7-1"><title>In vitro potency outcomes</title><p>Fifteen studies reported in vitro potency outcomes, including viability (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>) with 68 experiments and 32 different outcome measures. All reported in vitro outcomes can be found in <xref ref-type="table" rid="table6">Table 6</xref>. Of the 68 experiments, 9 were significantly different at the 0.05 level or less, with 7 that favoured freshly cultured and 2 that favoured cryopreserved MSCs (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><table-wrap id="table6" position="float"><label>Table 6.</label><caption><title>In vitro outcomes where freshly cultured vs. cryopreserved MSCs were compared directly.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Study</th><th align="left" valign="bottom">Outcome</th><th align="left" valign="bottom">Assay Used</th><th align="left" valign="bottom">Number (n)</th><th align="left" valign="bottom">Type and Source of MSCs</th><th align="left" valign="bottom">Time of cell preparation without MSC (hr)</th><th align="left" valign="bottom">Time of outcome measurement from MSC intervention (hr)</th><th align="left" valign="bottom">Concentration of MSCs</th><th align="left" valign="bottom">Pre-Treatment of MSCs</th><th align="left" valign="bottom">Negative Control (NC)</th><th align="left" valign="bottom">Positive Control (PC)</th><th align="left" valign="bottom">p-value for Fresh MSCs vs. control</th><th align="left" valign="bottom">p-value for Frozen MSCs vs. control</th><th align="left" valign="bottom">Fresh or Frozen MSC more effective?</th><th align="left" valign="bottom">p-value for Fresh vs. Frozen comparison</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref></td><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Trypan Blue</td><td align="left" valign="bottom">Fresh/Cultured (12); cryo &lt;1 yr(12); cryo &gt;3 yrs (5)</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Fresh/Cultured MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Apoptosis</td><td align="left" valign="bottom">Annexin V (and flow cytometry)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Fresh/Cultured MSCs were cryopreserved and then cultured for up to 5 days</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Cultured cells incubated with H<sub>2</sub>O<sub>2</sub> (2 mmol/L) for 2 hr</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Angiogenesis: Number of master junctions (branching points)</td><td align="left" valign="bottom">Matrigel/Human umbilical vein endothelial cell (HUVEC) tube formation assay</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">1 × 10<sup>6</sup> cells</td><td align="left" valign="bottom">Fresh/Cultured MSCs were cryopreserved and then cultured for up to 5 days; fresh and cryo co-cultured in basal media</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">HUVEC in Basal Media and HUVECs in Basal media with VEGF (100 ng/mL)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Angiogenesis: segment/tube length</td><td align="left" valign="bottom">Matrigel/Human umbilical vein endothelial cell (HUVEC) tube formation assay</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">1 × 10<sup>6</sup> cells</td><td align="left" valign="bottom">Fresh/Cultured MSCs were cryopreserved and then cultured for up to 5 days; fresh and cryo co-cultured in basal media</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">HUVEC in Basal Media and HUVECs in Basal media with VEGF (100 ng/mL)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Angiogenesis:total mesh area</td><td align="left" valign="bottom">Matrigel/Human umbilical vein endothelial cell (HUVEC) tube formation assay</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Human Umbilical Cord MSCs</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">1 × 10<sup>6</sup> cells</td><td align="left" valign="bottom">Fresh/Cultured MSCs were cryopreserved and then cultured for up to 5 days; fresh and cryo co-cultured in basal media</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">HUVEC in Basal Media and HUVECs in Basal media with VEGF (100 ng/mL)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref></td><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">TUNEL staining via Apo-Direct Apoptosis Detection Kit</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Human MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">30,000 MSCs</td><td align="left" valign="bottom">Both fresh and frozen cells were washed twice, resuspended in PBS and analyzed immediately or after 1 hr storage on wet ice</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">TUNEL staining via Apo-Direct Apoptosis Detection Kit</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Human MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">30,000 MSCs</td><td align="left" valign="bottom">Both fresh and frozen cells were washed twice, resuspended in PBS and analyzed immediately or after 1 hr storage on wet ice</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.001</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">TUNEL staining via Apo-Direct Apoptosis Detection Kit</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Human MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">72</td><td align="left" valign="bottom">30,000 MSCs</td><td align="left" valign="bottom">Both fresh and frozen cells were washed twice, resuspended in PBS and analyzed immediately or after 1 hr storage on wet ice</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>=0.002</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Metabolic Activity (measured by XXT)</td><td align="left" valign="bottom">XTT Assay</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">15,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.352</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Metabolic Activity (measured by XXT)</td><td align="left" valign="bottom">XTT Assay</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">15,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.312</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Metabolic Activity (measured by XXT)</td><td align="left" valign="bottom">XTT Assay</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human MSCs</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">72</td><td align="left" valign="bottom">15,000MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.971</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IDO activity: unstimulated MSC</td><td align="left" valign="bottom">Concentration of kynurenine in conditioned media</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.998</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IDO activity:MSC exposed to IFN-y</td><td align="left" valign="bottom">Concentration of kynurenine in conditioned media</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.099</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IDO activity: MSC exposed to IFN-y+TNF a</td><td align="left" valign="bottom">Concentration of kynurenine in conditioned media</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.951</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">GDF-15: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Frozen better</td><td align="left" valign="bottom"><italic>P</italic>=0.01</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">GDF-15: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.99</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IGFBP-2: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.32</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IGFBP-2: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.68</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IGFBP-3: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.47</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IGFBP-3: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.75</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IGFBP-4: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.39</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IGFBP-6: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.69</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">IGFBP-6: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>=0.03</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Insulin: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.71</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">OPG: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.39</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">OPG: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.65</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">PDGF-AA: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.43</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">PDGF-AA: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Frozen better</td><td align="left" valign="bottom"><italic>P</italic>=0.04</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">PIGF: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.83</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">SCF R: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.06</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">TGFb1: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">TGFb1: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>=0.05</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">VEGF: unstimulated</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.30</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">VEGF: stimulated with IFN-y/TNF-a</td><td align="left" valign="bottom">Human Growth Factor Array Q1</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Human MSC</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">200,000 MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Media Control</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS<break/><italic>P</italic>=0.96</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref></td><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Trypan Blue</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Trypan Blue</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Trypan Blue</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Trypan Blue</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Viable Cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Viable Cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Viable Cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Viable Cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability(Early apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability(Early apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability(Early apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability(Early apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Late apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Late apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Late apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Viability (Late apoptotic cells)</td><td align="left" valign="bottom">Annexin V+Propidium iodide (AV/PI)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Phagocytosis</td><td align="left" valign="bottom">PBMCs pre-treated with LPS the co-culture with MSC at ratio of 1:5 for 24 hr</td><td align="char" char="ndash" valign="bottom">3–6</td><td align="left" valign="bottom">Human BM MSC: Donor 1</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Naive PBMC</td><td align="left" valign="bottom">LPS treated PBMC</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.0001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Phagocytosis</td><td align="left" valign="bottom">PBMCs pre-treated with LPS the co-culture with MSC at ratio of 1:5 for 24 hr</td><td align="char" char="ndash" valign="bottom">3–6</td><td align="left" valign="bottom">Human BM MSC: Donor 2</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Naive PBMC</td><td align="left" valign="bottom">LPS treated PBMC</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">NS</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Phagocytosis</td><td align="left" valign="bottom">PBMCs pre-treated with LPS the co-culture with MSC at ratio of 1:5 for 24 hr</td><td align="char" char="ndash" valign="bottom">3–6</td><td align="left" valign="bottom">Human BM MSC: Donor 3</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Naive PBMC</td><td align="left" valign="bottom">LPS treated PBMC</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Permeability</td><td align="left" valign="bottom">Endothelial cell (EC) treated with LPS for 6 hr then co-culture with MSC for 24 hr at ratio of 1:2 followed by adding FITC-dextran to the transwell insert</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM MSC: Donor 1</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Non-treated EC</td><td align="left" valign="bottom">LPS treated EC</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Permeability</td><td align="left" valign="bottom">Endothelial cell (EC) treated with LPS for 6 hr then co-culture with MSC for 24 hr at ratio of 1:2 followed by adding FITC-dextran to the transwell insert</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM MSC: Donor 2</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Non-treated EC</td><td align="left" valign="bottom">LPS treated EC</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.01</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Permeability</td><td align="left" valign="bottom">Endothelial cell (EC) treated with LPS for 6 hr then co-culture with MSC for 24 hr at ratio of 1:2 followed by adding FITC-dextran to the transwell insert</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Human BM MSC: Donor 3</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Non-treated EC</td><td align="left" valign="bottom">LPS treated EC</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">PC: <italic>P</italic>&lt;0.001</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref></td><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">72</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">96</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">120</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">144</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">168</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">192</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">216</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">240</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">264</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">288</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Growth Curve</td><td align="left" valign="bottom">Countess automated cell counter</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">312</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">Frozen cells were thawed in distilled water at 36 °C for 45–60 s then enzymatically detached from mesh and added in re-warmed media with 15% FBS and washed twice at 1200 rpm for 5 min</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">CD 105 expression</td><td align="left" valign="bottom">Antibody assay</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Overnight</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Primary antibodies (1:100 dilutions) were<break/>used for localizing different markers (CD73, CD90, CD105, CD34) with<break/>an overnight incubation period at 4 °C.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">CD 90 expression</td><td align="left" valign="bottom">Antibody assay</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Overnight</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Primary antibodies (1:100 dilutions) were<break/>used for localizing different markers (CD73, CD90, CD105, CD34) with<break/>an overnight incubation period at 4 °C.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">CD 73 expression</td><td align="left" valign="bottom">Antibody assay</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Overnight</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Primary antibodies (1:100 dilutions) were<break/>used for localizing different markers (CD73, CD90, CD105, CD34) with<break/>an overnight incubation period at 4 °C.</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Population Doubling Time</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Canine BM</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">1 × 10<sup>4</sup> cells/ml</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom" rowspan="4"><xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref></td><td align="left" valign="bottom">Metabolic Activity/Proliferation rate</td><td align="left" valign="bottom">Alamar Blue</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Human Adipose</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">48</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">MSCs culture in PS1D-based gel</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom">Metabolic Activity/Proliferation rate</td><td align="left" valign="bottom">Alamar Blue</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Human Adipose</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">96</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">MSCs culture in PS1D-based gel</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom">Metabolic Activity/Proliferation rate</td><td align="left" valign="bottom">Alamar Blue</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Human Adipose</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">144</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">MSCs culture in PS1D-based gel</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Alamar Blue</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Human Adipose</td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref></td><td align="left" valign="bottom">Antioxidant Concentration<break/>(2 fresh groups:GFP-MSC and HO-1 MSC)</td><td align="left" valign="bottom">Antioxidant Assay</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Canine adipose</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">Lentivirus-mediated GFP and HO-1 gene insertion into Ad-MSCs</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Fresh better</td><td align="left" valign="bottom"><italic>P</italic>&lt;0.05</td></tr><tr><td align="left" valign="bottom" rowspan="3"><xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref></td><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Trypan Blue</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0, 2, 4, 24, 48 hr</td><td align="left" valign="bottom">1×10<sup>4</sup> cells/well</td><td align="left" valign="bottom">None</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Viability</td><td align="left" valign="bottom">Water-soluble tetrazolium salt (WST) assay</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0, 2, 4, 24, 48 hr</td><td align="left" valign="bottom">1×10^4 cells/well</td><td align="left" valign="bottom">None</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom">Population Doubling Time</td><td align="left" valign="bottom">Cell counting</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Human Umbilical Cord</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">4, 8, 12, 16, 20 days</td><td align="left" valign="bottom">3×10^3 cells/cm^2</td><td align="left" valign="bottom">None</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref></td><td align="left" valign="bottom">Biolumnescence</td><td align="left" valign="bottom">IVIS Lumina XRMS series III instrument (SPI, Tokyo,<break/>Japan)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Rat Synovial MSCs</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Same day</td><td align="left" valign="bottom">Varying concentrations</td><td align="left" valign="bottom">None</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">↔</td><td align="left" valign="bottom">NS</td></tr></tbody></table><table-wrap-foot><fn><p>N/A = Not applicable (e.g. if the experiment set up did not include a particular variable). NR = Not reported (e.g. if a particular variable was part of the experiment set up but not explicitly reported on in results section or graph).</p></fn></table-wrap-foot></table-wrap><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>In-vitro potency outcomes.</title><p>All the in-vitro reported outcomes are displayed below. Number of experiments represent the number of separate comparisons between freshly-cultured and cryopreserved MSCs on surrogate measures of in vivo efficacy.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75053-fig4-v1.tif"/></fig></sec><sec id="s3-7-2"><title>In vitro potency: protein (cytokine) expression and secretion</title><p>A total of four studies (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>) reported in vitro protein (cytokine) expression and secretion outcomes. Of the 33 experiments, five demonstrated a significant difference at the 0.05 level or less, with two favouring cryopreserved and three favouring freshly cultured MSCs (<xref ref-type="table" rid="table5">Table 5</xref>).</p></sec><sec id="s3-7-3"><title>In vitro potency: co-culture assays</title><p>Three studies reported in vitro co-culture assay outcomes (7 separate experiments) to assess the impact of MSCs on responder cell proliferation (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>). All three studies used PBMCs (peripheral blood mononuclear cell) activated with CD3 and CD28 as the responder cells. The studies employed variable MSC:Responder cell ratios and duration of culture. All three studies found no significant difference in potency for cryopreserved as compared to freshly-cultured MSCs at varying concentrations of MSCs to responder cells (<xref ref-type="table" rid="table7">Table 7</xref>).</p><table-wrap id="table7" position="float"><label>Table 7.</label><caption><title>Summary of all in vitro PBMC Proliferation assays from included studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Study</th><th align="left" valign="bottom" rowspan="2">MSCs Used</th><th align="left" valign="bottom" rowspan="2">Solution</th><th align="left" valign="bottom" rowspan="2">Addition to solution</th><th align="left" valign="bottom" rowspan="2">Responder Cells</th><th align="left" valign="bottom" rowspan="2">Fresh vs. Frozen Comparison</th><th align="left" valign="bottom" rowspan="2">Duration of Culture</th><th align="left" valign="bottom" rowspan="2">Proliferation Measurement</th><th align="left" valign="bottom" colspan="6">Ratio (MSC:Responder Cells)</th></tr><tr><th align="char" char="." valign="bottom">1:1</th><th align="char" char="." valign="bottom">1:3</th><th align="char" char="." valign="bottom">1:6</th><th align="char" char="." valign="bottom">1:10</th><th align="char" char="." valign="bottom">1:12</th><th align="char" char="." valign="bottom">1:50</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref></td><td align="left" valign="bottom">Cultured and Freshly-thawed MSCs were irradiated<break/>with 50 Gy prior to use</td><td align="left" valign="bottom">RPMI</td><td align="left" valign="bottom">5% HEPES, 5% Pen-Strep, 5% NaPyr and 5% human serum</td><td align="left" valign="bottom">PBMC stimulated with anti-CD3, anti-CD28, and IL-2.</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">16 hr</td><td align="left" valign="bottom">Percentage of T cells proliferation/<break/>suppression</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Yes</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref></td><td align="left" valign="bottom">Cultured and Freshly-thawed MSCs</td><td align="left" valign="bottom">RPMI</td><td align="left" valign="bottom">10% (v/v) FBS, 1% (v/v) Penicillin/Streptomycin, and 1%<break/>(v/v) L-glutamine</td><td align="left" valign="bottom">PBMC stimulated with 250,000 Human T-activator<break/>CD3+/D28+Dynabeads</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">144 hr</td><td align="left" valign="bottom">CFSE Cell Proliferation Kit</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref></td><td align="left" valign="bottom">Cultured and Freshly-thawed MSCs</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">PBMC stimulated with Dynabeads Human T-Activator CD3/CD28</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">120 hr</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></sec></sec><sec id="s3-8"><title>Viability</title><p>Seventeen studies (<xref ref-type="bibr" rid="bib14">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Devaney et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Curley et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Bharti et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Horie et al., 2020a</xref>; <xref ref-type="bibr" rid="bib46">Lohan et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Perlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Rogulska et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Horie et al., 2020b</xref>) reported post-thaw viability of cryopreserved MSCs, the range was from 60% to 98% across various time points since thawing. The viability of freshly cultured MSCs ranged from 91% to 99%, also assessed at various time points. Only seven studies reported on 25 viability experiments which compared viability directly between freshly cultured and cryopreserved MSCs (<xref ref-type="bibr" rid="bib28">Gramlich et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Somal et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib36">Horiuchi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Horie et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Yea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bárcia et al., 2017</xref>) Of the 25 experiments, 9 (36%) favoured freshly cultured MSCs (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Comparison of viability.</title><p>Experiments where viability at varying time points of freshly-cultured and cryopreserved MSCs were compared directly are presented below.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75053-fig5-v1.tif"/></fig></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>Our study is the first comprehensive pre-clinical systematic review to examine the effect of cryopreservation on the in vivo efficacy and in vitro potency of MSCs in animal models of inflammation. Across the 18 included studies, our review found that 251 out of 257 (97.6%) of the in vivo pre-clinical efficacy outcomes demonstrated no statistically significant differences between cryopreserved and freshly cultured MSCs at a p value of&lt;0.05<italic>.</italic> When evaluating the results of a large, heterogeneous group of studies with different outcome measures comparing freshly cultured versus cryopreserved MSCs for efficacy and potency, it is useful to compare the results to what one would expect to see if (a) there were truly no difference or if (b) there truly were a difference. In the former case, where all differences would be due exclusively to Type I error, we would expect to see roughly 5% of the p-values as statistically significant. Furthermore, when a difference was statistically significant, we would expect it to be equally likely to favor freshly cultured versus cryopreserved or vice versa. In the latter case, where there truly is a difference, we would expect to see more than 5% of the p-values of all experiments as statistically significant and a strong concordance in the sense that most would favor the same group. We argue that our results for in vivo preclinical efficacy are consistent with pure Type 1 error (2.6% were statistically significant with roughly half favoring freshly cultured and half favoring cryopreserved MSCs). For in vitro potency, the results are somewhat less clear cut. We found 13% (95% Confidence Interval: 5–21%) were significantly different; 7 favored freshly cultured and 2 favored cryopreserved MSCs. Given that the confidence interval for the rate of statistical significance does not exclude 5% and that 2 of the 9 significant results favored cryopreserved MSCs, it does not represent strong evidence of a significant difference in in vitro potency. In terms of viability, the evidence supports reduced viability in cryopreserved versus freshly cultured MSCs, which is in keeping with previously published studies (<xref ref-type="bibr" rid="bib18">Eaker et al., 2013</xref>; <xref ref-type="bibr" rid="bib61">Robb et al., 2019</xref>).</p><p>Cryopreservation under safe and quality-controlled conditions remains critical for future real-world applications of MSC therapies (<xref ref-type="bibr" rid="bib1">Abazari et al., 2017</xref>) by easing the logistical burden of supplying freshly cultured MSCs, enabling quality control and standardization of the cell preparation, and to facilitate the logistical transport of cellular products to hospitals. Some studies have shown that cryopreservation does not negatively impact MSCs; even if stored in cryopreservation for up to 23–24 years (<xref ref-type="bibr" rid="bib65">Shen et al., 2012</xref>; <xref ref-type="bibr" rid="bib3">Badowski et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Marquez-Curtis et al., 2015</xref>). However, other studies have demonstrated mixed effects with both short-term and long-term cryopreservation (<xref ref-type="bibr" rid="bib16">Dariolli et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">Kotobuki et al., 2005</xref>). Notably, most of these studies lack a clear assessment of MSC in vivo function. A recent systematic review of 41 in vitro studies that examined bone-marrow-derived MSCs (BM-MSCs) demonstrated that MSC cell morphology, marker expression, proliferation potential and tri-lineage differentiation capability were unaffected by stresses imposed by freezing and thawing, whereas viability, attachment to plasticware and migration, genomic stability and paracrine function of MSCs demonstrated conflicting results (<xref ref-type="bibr" rid="bib4">Bahsoun et al., 2019</xref>). Out of their included 41 studies, only eight studied MSCs’ immune function (88% conducted co-culture assays) post-thaw with four studies concluding a negative effect and four concluding no effect of cryopreservation on MSC in vitro immune function. Interestingly, this review found that the immediate post-thaw viability varied from about 50% to 100% among the included studies; 16 studies reported no change in viability immediately after thawing and 10 studies reported significantly lower viability (<xref ref-type="bibr" rid="bib4">Bahsoun et al., 2019</xref>).</p><p>Cryopreserved MSCs have a higher percentage of apoptotic cells than MSCs from fresh cultures (<xref ref-type="bibr" rid="bib30">Haack-Sørensen and Kastrup, 2011</xref>). Many factors could contribute to the diminished viability and functionality of cryopreserved MSCs, including the source of MSCs, rate of cooling, storage temperature and period, method of recovery from cryopreservation, and the cryoprotectants used (<xref ref-type="bibr" rid="bib48">Marquez-Curtis et al., 2015</xref>). Cryopreserved MSCs are commonly frozen in 5–10% DMSO and or fetal bovine serum (FBS) (<xref ref-type="bibr" rid="bib45">Liu et al., 2010</xref>; <xref ref-type="bibr" rid="bib63">Rowley et al., 1999</xref>), but there are disadvantages of using these agents. DMSO is used extensively as a cryopreservation agent in the autologous hematopoietic stem cell transplant population and may be toxic at higher concentrations (<xref ref-type="bibr" rid="bib2">Alessandrino et al., 1999</xref>). Adverse events have been associated with DMSO (most common are nausea, vomiting, weakness) (<xref ref-type="bibr" rid="bib54">Mitrus et al., 2018</xref>) but a recent systematic review that examined safety of MSCs in randomized controlled trials (RCTs) found no serious adverse event safety signals for freshly cultured versus cryopreserved MSCs (<xref ref-type="bibr" rid="bib70">Thompson et al., 2020</xref>). Furthermore, the use of animal proteins from FBS may theoretically increase the risk of transferring infectious agents or stimulating unwanted immunological responses. Despite the continued search for the most optimal cryoprotectant, no consensus has been developed on the safest type and concentration of cryoprotectant to use (<xref ref-type="bibr" rid="bib25">Galipeau and Sensébé, 2018</xref>). Optimizing the rate of cooling is as important as the thawing process, both of which can further contribute to cell injury. Apoptotic and necrotic pathways are activated in these cells 6–48 h post-thaw in response to low temperature exposure (<xref ref-type="bibr" rid="bib12">Chinnadurai et al., 2016</xref>; <xref ref-type="bibr" rid="bib7">Baust et al., 2009</xref>). Remarkably, many studies demonstrate that MSCs, isolated from diverse sources, cryopreserved using various cooling rates, in the presence of different cryoprotectants, stored for various lengths of time, and at various sub-zero temperatures still retain their biological properties post-thaw except for viability (<xref ref-type="bibr" rid="bib48">Marquez-Curtis et al., 2015</xref>). Viability of MSCs is considered an important indicator of cryopreservation success where at least 90% viability for fresh MSC product and 70% viability for cryopreserved MSC product are considered the benchmark for pre-clinical application (<xref ref-type="bibr" rid="bib61">Robb et al., 2019</xref>). One provocative study found that recipient cytotoxic cell activity causing apoptosis of infused MSCs or infusion of ex-vivo apoptotic MSCs and suggested it is one of the proposed mechanisms of immunomodulation for MSCs and the lower viability (or increased number of apoptotic cells) may in fact play a positive role in reducing the host inflammatory state (<xref ref-type="bibr" rid="bib26">Galleu et al., 2017</xref>). In a safety systematic review of MSC randomized trials, only 52% and 14.5% reported on viability and potency respectively (<xref ref-type="bibr" rid="bib70">Thompson et al., 2020</xref>). Our systematic review also found that 13 of 18 included studies received an “unclear” risk of bias in 5 out of 10 domains of the SYRCLE risk of bias tool due to insufficient and unclear reporting of important variables (eg. cryopreservation process, storage conditions, blinding, etc.). Due to the importance of reporting risk of bias elements as well as the cryopreservation and thaw process that could impact MSC quantity, quality, and efficacy, interpretation of MSC research studies remains limited. We strongly encourage the standardized reporting of these parameters by authors, reviewers, and journal editors as markers of reporting quality and to enhance transparency, reproducibility, and interpretation of MSC research studies.</p><p>From the perspective of clinical research and potential efficacy of cryopreserved MSCs, a phase III randomized clinical trial that examined whether a cryopreserved MSC product, PROCHYMAL (Remestemcel-L), or placebo compared to standard second line therapies alone in children with acute graft-versus-host disease (aGVHD) showed that high risk patients were more likely to have a partial response at 28 days with Remestemcel. Furthermore, a recently published systematic review that examined 55 randomized trials which used a MSC product versus control/usual care not only suggested evidence for safety of cryopreserved MSCs but also potential efficacy. Of the 15 trials that studied a cryopreserved product, 5 of them (33%) found significant differences favoring cryopreserved MSCs in either the primary or secondary endpoints (<xref ref-type="bibr" rid="bib40">Kebriaei et al., 2020</xref>).</p><p>There are several strengths in this current systematic review. First, we have published our protocol which includes a transparent search strategy, pre-defined classifications for cryopreserved and freshly cultured MSCs and outcome measures, and minimal exclusion criteria. Ours is the first comprehensive systematic review assessing the in vivo efficacy of cryopreserved MSCs when directly compared to freshly cultured MSCs in animal models of inflammation. All variables and experimental details were collected and summarized systematically. Given the breadth and variety of in vivo and in vitro outcome measures, we report our data by considering each experiment where cryopreserved and freshly cultured MSCs are compared as an individual hypothesis test. Our review provides the totality of the existing pre-clinical evidence base, and we hope it will provide additional rationale for considering a cryopreserved MSC product for use in pre-clinical studies and clinical trials, and help identify research gaps for future related research (<xref ref-type="bibr" rid="bib25">Galipeau and Sensébé, 2018</xref>).</p><p>Our study did have some limitations. Given our emphasis on including studies that examined MSC in vivo efficacy, we excluded all studies that only conducted in vitro studies. This led to a significant number of cryopreserved MSC studies being excluded and hence, our in vitro outcome reporting may be incomplete. However, when considering whether cryopreserved MSCs may be efficacious in clinical settings, pre-clinical in vivo efficacy outcomes might be more convincing than in vitro studies alone. Most of the preclinical studies did not provide sufficient information to adequately perform the SYRCLE risk of bias assessment, resulting in unclear reporting in at least three bias domains or more in all but one study, despite our attempts to contact authors to obtain further study details. Our ability to conduct meta-analyses on our primary outcome measures and according to subgroups was significantly limited by the heterogeneity of animal models included and breadth of outcomes measured. Finally, it is possible that other important in vivo pre-clinical efficacy or in vitro potency outcomes were not reported in our review. However, we designed and then conducted a systematic and transparent search using a pre-published protocol to enhance transparency and reproducibility, and to ensure we captured the totality of the evidence according to our study question. Questions remain related to MSC mechanisms of action in response to different immune stimuli, such as the effect of xenotransplanation. Further research to understand where there may be differences in effects of syngeneic MSCs as compared to xenogenic MSCs in models of inflammatory diseases related to HLA stimulation/expression, co-stimulatory molecules, paracrine factors, and species-specific cytokines and receptors may assist successful translation in human clinical trials (<xref ref-type="bibr" rid="bib60">Prockop and Lee, 2017</xref>). Our review reported pre-dominantly on different biological outcome measures which does not provide a measure of overall animal health in a given inflammatory animal model. However, certain biological outcomes may be part of the mechanistic/causal pathway related to the disease (in the animal and humans) and may be considered as important surrogates for overall health. These biological outcomes in pre-clinical studies may also help to inform the exploration of them as predictive or prognostic variables in human clinical trials.</p><sec id="s4-1"><title>Conclusions</title><p>Our study provides a comprehensive systematic review of pre-clinical studies comparing cryopreserved versus freshly cultured MSCs in animal models of inflammation. Our findings suggest that for the majority of outcomes measured in this review, cryopreservation does not negatively impact in vivo efficacy or in vitro potency of MSCs. With our systematic summary of the current evidence base, we hope it may provide MSC basic and research scientists additional rationale for considering a cryopreserved MSC product for use in pre-clinical studies and clinical trials, and help identify research gaps for future MSC-related research. We also strongly encourage the standardized reporting of important parameters related to risk of bias, MSC processing characteristics (e.g. cryopreservation and thawing protocols), storage conditions, viability, and potency as markers of study quality and to enhance transparency, reproducibility, and interpretation of MSC research studies.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Methodology, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Methodology, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Search strategy.</title></caption><media xlink:href="elife-75053-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>PRISMA checklist.</title></caption><media xlink:href="elife-75053-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>AGREE-II tool prompting questions.</title></caption><media xlink:href="elife-75053-supp3-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Data collection items.</title></caption><media xlink:href="elife-75053-supp4-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-75053-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed in our review are provided in the attached tables and figures.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We acknowledge Emily Doxtator for her help in the initial screening of studies, Risa Shorr for her help in conducting the scientific, comprehensive search strategy, and Diana Wolfe for her contribution to the development of the protocol for this systematic review. We acknowledge the Ontario Institute for Regenerative Medicine and the Stem Cell Network for funding this systematic review. We also acknowledge the following authors who responded to our request for further information: Taru Sharma, Shahd Horie, Daniel O’Toole, and James Ankrum.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abazari</surname><given-names>A</given-names></name><name><surname>Hawkins</surname><given-names>BJ</given-names></name><name><surname>Clarke</surname><given-names>DM</given-names></name><name><surname>Mathew</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – MSC Model Case Study</article-title><source>Cell and Gene Therapy Insights</source><volume>3</volume><fpage>853</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.18609/cgti.2017.082</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alessandrino</surname><given-names>P</given-names></name><name><surname>Bernasconi</surname><given-names>P</given-names></name><name><surname>Caldera</surname><given-names>D</given-names></name><name><surname>Colombo</surname><given-names>A</given-names></name><name><surname>Bonfichi</surname><given-names>M</given-names></name><name><surname>Malcovati</surname><given-names>L</given-names></name><name><surname>Klersy</surname><given-names>C</given-names></name><name><surname>Martinelli</surname><given-names>G</given-names></name><name><surname>Maiocchi</surname><given-names>M</given-names></name><name><surname>Pagnucco</surname><given-names>G</given-names></name><name><surname>Varettoni</surname><given-names>M</given-names></name><name><surname>Perotti</surname><given-names>C</given-names></name><name><surname>Bernasconi</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases</article-title><source>Bone Marrow Transplantation</source><volume>23</volume><fpage>533</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/sj.bmt.1701609</pub-id><pub-id pub-id-type="pmid">10217182</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badowski</surname><given-names>M</given-names></name><name><surname>Muise</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mixed effects of long-term frozen storage on cord tissue stem cells</article-title><source>Cytotherapy</source><volume>16</volume><fpage>1313</fpage><lpage>1321</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2014.05.020</pub-id><pub-id pub-id-type="pmid">25108655</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahsoun</surname><given-names>S</given-names></name><name><surname>Coopman</surname><given-names>K</given-names></name><name><surname>Akam</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The impact of cryopreservation on bone marrow-derived mesenchymal stem cells: a systematic review</article-title><source>Journal of Translational Medicine</source><volume>17</volume><elocation-id>397</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-019-02136-7</pub-id><pub-id pub-id-type="pmid">31783866</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bárcia</surname><given-names>RN</given-names></name><name><surname>Santos</surname><given-names>JM</given-names></name><name><surname>Teixeira</surname><given-names>M</given-names></name><name><surname>Filipe</surname><given-names>M</given-names></name><name><surname>Pereira</surname><given-names>ARS</given-names></name><name><surname>Ministro</surname><given-names>A</given-names></name><name><surname>Água-Doce</surname><given-names>A</given-names></name><name><surname>Carvalheiro</surname><given-names>M</given-names></name><name><surname>Gaspar</surname><given-names>MM</given-names></name><name><surname>Miranda</surname><given-names>JP</given-names></name><name><surname>Graça</surname><given-names>L</given-names></name><name><surname>Simões</surname><given-names>S</given-names></name><name><surname>Santos</surname><given-names>SCR</given-names></name><name><surname>Cruz</surname><given-names>P</given-names></name><name><surname>Cruz</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Umbilical cord tissue-derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing</article-title><source>Cytotherapy</source><volume>19</volume><fpage>360</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2016.11.008</pub-id><pub-id pub-id-type="pmid">28040463</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>F</given-names></name><name><surname>Lechanteur</surname><given-names>C</given-names></name><name><surname>Willems</surname><given-names>E</given-names></name><name><surname>Bruck</surname><given-names>F</given-names></name><name><surname>Baudoux</surname><given-names>E</given-names></name><name><surname>Seidel</surname><given-names>L</given-names></name><name><surname>Vanbellinghen</surname><given-names>J-F</given-names></name><name><surname>Hafraoui</surname><given-names>K</given-names></name><name><surname>Lejeune</surname><given-names>M</given-names></name><name><surname>Gothot</surname><given-names>A</given-names></name><name><surname>Fillet</surname><given-names>G</given-names></name><name><surname>Beguin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning</article-title><source>Biology of Blood and Marrow Transplantation</source><volume>16</volume><fpage>838</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1016/j.bbmt.2010.01.011</pub-id><pub-id pub-id-type="pmid">20109568</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baust</surname><given-names>JG</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Baust</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cryopreservation: An emerging paradigm change</article-title><source>Organogenesis</source><volume>5</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.4161/org.5.3.10021</pub-id><pub-id pub-id-type="pmid">20046670</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharti</surname><given-names>MK</given-names></name><name><surname>Bhat</surname><given-names>IA</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Shabir</surname><given-names>U</given-names></name><name><surname>Peer</surname><given-names>BA</given-names></name><name><surname>Indu</surname><given-names>B</given-names></name><name><surname>Bhat</surname><given-names>AR</given-names></name><name><surname>Kumar</surname><given-names>GS</given-names></name><name><surname>Chandra</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>GT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Effect of cryopreservation on therapeutic potential of canine bone marrow derived mesenchymal stem cells augmented mesh scaffold for wound healing in guinea pig</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>121</volume><elocation-id>109573</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2019.109573</pub-id><pub-id pub-id-type="pmid">31810116</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>AJ</given-names></name><name><surname>McNiece</surname><given-names>IK</given-names></name><name><surname>Hare</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mesenchymal stem cell therapy for cardiac repair</article-title><source>Methods in Molecular Biology</source><volume>660</volume><fpage>65</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1007/978-1-60761-705-1_5</pub-id><pub-id pub-id-type="pmid">20680813</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caplan</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Why are MSCs therapeutic? New data: new insight</article-title><source>The Journal of Pathology</source><volume>217</volume><fpage>318</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1002/path.2469</pub-id><pub-id pub-id-type="pmid">19023885</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YS</given-names></name><name><surname>Ahn</surname><given-names>SY</given-names></name><name><surname>Yoo</surname><given-names>HS</given-names></name><name><surname>Sung</surname><given-names>SI</given-names></name><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Oh</surname><given-names>WI</given-names></name><name><surname>Park</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial</article-title><source>The Journal of Pediatrics</source><volume>164</volume><fpage>966</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2013.12.011</pub-id><pub-id pub-id-type="pmid">24508444</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinnadurai</surname><given-names>R</given-names></name><name><surname>Copland</surname><given-names>IB</given-names></name><name><surname>Garcia</surname><given-names>MA</given-names></name><name><surname>Petersen</surname><given-names>CT</given-names></name><name><surname>Lewis</surname><given-names>CN</given-names></name><name><surname>Waller</surname><given-names>EK</given-names></name><name><surname>Kirk</surname><given-names>AD</given-names></name><name><surname>Galipeau</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing</article-title><source>Stem Cells (Dayton, Ohio)</source><volume>34</volume><fpage>2429</fpage><lpage>2442</lpage><pub-id pub-id-type="doi">10.1002/stem.2415</pub-id><pub-id pub-id-type="pmid">27299362</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connick</surname><given-names>P</given-names></name><name><surname>Kolappan</surname><given-names>M</given-names></name><name><surname>Patani</surname><given-names>R</given-names></name><name><surname>Scott</surname><given-names>MA</given-names></name><name><surname>Crawley</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>X-L</given-names></name><name><surname>Richardson</surname><given-names>K</given-names></name><name><surname>Barber</surname><given-names>K</given-names></name><name><surname>Webber</surname><given-names>DJ</given-names></name><name><surname>Wheeler-Kingshott</surname><given-names>CAM</given-names></name><name><surname>Tozer</surname><given-names>DJ</given-names></name><name><surname>Samson</surname><given-names>RS</given-names></name><name><surname>Thomas</surname><given-names>DL</given-names></name><name><surname>Du</surname><given-names>M-Q</given-names></name><name><surname>Luan</surname><given-names>SL</given-names></name><name><surname>Michell</surname><given-names>AW</given-names></name><name><surname>Altmann</surname><given-names>DR</given-names></name><name><surname>Thompson</surname><given-names>AJ</given-names></name><name><surname>Miller</surname><given-names>DH</given-names></name><name><surname>Compston</surname><given-names>A</given-names></name><name><surname>Chandran</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments</article-title><source>Trials</source><volume>12</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.1186/1745-6215-12-62</pub-id><pub-id pub-id-type="pmid">21366911</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>FF</given-names></name><name><surname>Borg</surname><given-names>ZD</given-names></name><name><surname>Goodwin</surname><given-names>M</given-names></name><name><surname>Sokocevic</surname><given-names>D</given-names></name><name><surname>Wagner</surname><given-names>D</given-names></name><name><surname>McKenna</surname><given-names>DH</given-names></name><name><surname>Rocco</surname><given-names>PRM</given-names></name><name><surname>Weiss</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice</article-title><source>Stem Cells Translational Medicine</source><volume>4</volume><fpage>615</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.5966/sctm.2014-0268</pub-id><pub-id pub-id-type="pmid">25925837</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curley</surname><given-names>GF</given-names></name><name><surname>Jerkic</surname><given-names>M</given-names></name><name><surname>Dixon</surname><given-names>S</given-names></name><name><surname>Hogan</surname><given-names>G</given-names></name><name><surname>Masterson</surname><given-names>C</given-names></name><name><surname>O’Toole</surname><given-names>D</given-names></name><name><surname>Devaney</surname><given-names>J</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cryopreserved, Xeno-Free Human Umbilical Cord Mesenchymal Stromal Cells Reduce Lung Injury Severity and Bacterial Burden in Rodent <italic>Escherichia coli</italic>-Induced Acute Respiratory Distress Syndrome</article-title><source>Critical Care Medicine</source><volume>45</volume><fpage>e202</fpage><lpage>e212</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000002073</pub-id><pub-id pub-id-type="pmid">27861182</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dariolli</surname><given-names>R</given-names></name><name><surname>Bassaneze</surname><given-names>V</given-names></name><name><surname>Nakamuta</surname><given-names>JS</given-names></name><name><surname>Omae</surname><given-names>SV</given-names></name><name><surname>Campos</surname><given-names>LCG</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name><name><surname>Covas</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Porcine adipose tissue-derived mesenchymal stem cells retain their proliferative characteristics, senescence, karyotype and plasticity after long-term cryopreservation</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e67939</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0067939</pub-id><pub-id pub-id-type="pmid">23874472</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devaney</surname><given-names>J</given-names></name><name><surname>Horie</surname><given-names>S</given-names></name><name><surname>Masterson</surname><given-names>C</given-names></name><name><surname>Elliman</surname><given-names>S</given-names></name><name><surname>Barry</surname><given-names>F</given-names></name><name><surname>O’Brien</surname><given-names>T</given-names></name><name><surname>Curley</surname><given-names>GF</given-names></name><name><surname>O’Toole</surname><given-names>D</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Human mesenchymal stromal cells decrease the severity of acute lung injury induced by <italic>E. coli</italic> in the rat</article-title><source>Thorax</source><volume>70</volume><fpage>625</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2015-206813</pub-id><pub-id pub-id-type="pmid">25986435</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaker</surname><given-names>S</given-names></name><name><surname>Armant</surname><given-names>M</given-names></name><name><surname>Brandwein</surname><given-names>H</given-names></name><name><surname>Burger</surname><given-names>S</given-names></name><name><surname>Campbell</surname><given-names>A</given-names></name><name><surname>Carpenito</surname><given-names>C</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Fong</surname><given-names>T</given-names></name><name><surname>Karnieli</surname><given-names>O</given-names></name><name><surname>Niss</surname><given-names>K</given-names></name><name><surname>Van’t Hof</surname><given-names>W</given-names></name><name><surname>Wagey</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing</article-title><source>Stem Cells Translational Medicine</source><volume>2</volume><fpage>871</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.5966/sctm.2013-0050</pub-id><pub-id pub-id-type="pmid">24101671</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emadedin</surname><given-names>M</given-names></name><name><surname>Ghorbani Liastani</surname><given-names>M</given-names></name><name><surname>Fazeli</surname><given-names>R</given-names></name><name><surname>Mohseni</surname><given-names>F</given-names></name><name><surname>Moghadasali</surname><given-names>R</given-names></name><name><surname>Mardpour</surname><given-names>S</given-names></name><name><surname>Hosseini</surname><given-names>SE</given-names></name><name><surname>Niknejadi</surname><given-names>M</given-names></name><name><surname>Moeininia</surname><given-names>F</given-names></name><name><surname>Aghahossein Fanni</surname><given-names>A</given-names></name><name><surname>Baghban Eslaminejhad</surname><given-names>R</given-names></name><name><surname>Vosough Dizaji</surname><given-names>A</given-names></name><name><surname>Labibzadeh</surname><given-names>N</given-names></name><name><surname>Mirazimi Bafghi</surname><given-names>A</given-names></name><name><surname>Baharvand</surname><given-names>H</given-names></name><name><surname>Aghdami</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-Term Follow-up of Intra-articular Injection of Autologous Mesenchymal Stem Cells in Patients with Knee, Ankle, or Hip Osteoarthritis</article-title><source>Archives of Iranian Medicine</source><volume>18</volume><fpage>336</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">26058927</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>KM</given-names></name><name><surname>Hajjar</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mesenchymal Stem Cells &amp; Endothelial Function</article-title><source>EBioMedicine</source><volume>2</volume><fpage>376</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2015.04.015</pub-id><pub-id pub-id-type="pmid">26137582</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forbes</surname><given-names>GM</given-names></name><name><surname>Sturm</surname><given-names>MJ</given-names></name><name><surname>Leong</surname><given-names>RW</given-names></name><name><surname>Sparrow</surname><given-names>MP</given-names></name><name><surname>Segarajasingam</surname><given-names>D</given-names></name><name><surname>Cummins</surname><given-names>AG</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Herrmann</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy</article-title><source>Clinical Gastroenterology and Hepatology</source><volume>12</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2013.06.021</pub-id><pub-id pub-id-type="pmid">23872668</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>François</surname><given-names>M</given-names></name><name><surname>Copland</surname><given-names>IB</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Romieu-Mourez</surname><given-names>R</given-names></name><name><surname>Waller</surname><given-names>EK</given-names></name><name><surname>Galipeau</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing</article-title><source>Cytotherapy</source><volume>14</volume><fpage>147</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.3109/14653249.2011.623691</pub-id><pub-id pub-id-type="pmid">22029655</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galipeau</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?</article-title><source>Cytotherapy</source><volume>15</volume><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2012.10.002</pub-id><pub-id pub-id-type="pmid">23260081</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galipeau</surname><given-names>J</given-names></name><name><surname>Krampera</surname><given-names>M</given-names></name><name><surname>Barrett</surname><given-names>J</given-names></name><name><surname>Dazzi</surname><given-names>F</given-names></name><name><surname>Deans</surname><given-names>RJ</given-names></name><name><surname>DeBruijn</surname><given-names>J</given-names></name><name><surname>Dominici</surname><given-names>M</given-names></name><name><surname>Fibbe</surname><given-names>WE</given-names></name><name><surname>Gee</surname><given-names>AP</given-names></name><name><surname>Gimble</surname><given-names>JM</given-names></name><name><surname>Hematti</surname><given-names>P</given-names></name><name><surname>Koh</surname><given-names>MBC</given-names></name><name><surname>LeBlanc</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>I</given-names></name><name><surname>McNiece</surname><given-names>IK</given-names></name><name><surname>Mendicino</surname><given-names>M</given-names></name><name><surname>Oh</surname><given-names>S</given-names></name><name><surname>Ortiz</surname><given-names>L</given-names></name><name><surname>Phinney</surname><given-names>DG</given-names></name><name><surname>Planat</surname><given-names>V</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Stroncek</surname><given-names>DF</given-names></name><name><surname>Viswanathan</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Sensebe</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials</article-title><source>Cytotherapy</source><volume>18</volume><fpage>151</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2015.11.008</pub-id><pub-id pub-id-type="pmid">26724220</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galipeau</surname><given-names>J</given-names></name><name><surname>Sensébé</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities</article-title><source>Cell Stem Cell</source><volume>22</volume><fpage>824</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.05.004</pub-id><pub-id pub-id-type="pmid">29859173</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galleu</surname><given-names>A</given-names></name><name><surname>Riffo-Vasquez</surname><given-names>Y</given-names></name><name><surname>Trento</surname><given-names>C</given-names></name><name><surname>Lomas</surname><given-names>C</given-names></name><name><surname>Dolcetti</surname><given-names>L</given-names></name><name><surname>Cheung</surname><given-names>TS</given-names></name><name><surname>von Bonin</surname><given-names>M</given-names></name><name><surname>Barbieri</surname><given-names>L</given-names></name><name><surname>Halai</surname><given-names>K</given-names></name><name><surname>Ward</surname><given-names>S</given-names></name><name><surname>Weng</surname><given-names>L</given-names></name><name><surname>Chakraverty</surname><given-names>R</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Watt</surname><given-names>FM</given-names></name><name><surname>Orchard</surname><given-names>K</given-names></name><name><surname>Marks</surname><given-names>DI</given-names></name><name><surname>Apperley</surname><given-names>J</given-names></name><name><surname>Bornhauser</surname><given-names>M</given-names></name><name><surname>Walczak</surname><given-names>H</given-names></name><name><surname>Bennett</surname><given-names>C</given-names></name><name><surname>Dazzi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation</article-title><source>Science Translational Medicine</source><volume>9</volume><elocation-id>eaam7828</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aam7828</pub-id><pub-id pub-id-type="pmid">29141887</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Salazar</surname><given-names>M</given-names></name><name><surname>Gonzalez-Galofre</surname><given-names>ZN</given-names></name><name><surname>Casamitjana</surname><given-names>J</given-names></name><name><surname>Crisan</surname><given-names>M</given-names></name><name><surname>James</surname><given-names>AW</given-names></name><name><surname>Péault</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Five Decades Later, Are Mesenchymal Stem Cells Still Relevant?</article-title><source>Frontiers in Bioengineering and Biotechnology</source><volume>8</volume><elocation-id>148</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2020.00148</pub-id><pub-id pub-id-type="pmid">32185170</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gramlich</surname><given-names>OW</given-names></name><name><surname>Burand</surname><given-names>AJ</given-names></name><name><surname>Brown</surname><given-names>AJ</given-names></name><name><surname>Deutsch</surname><given-names>RJ</given-names></name><name><surname>Kuehn</surname><given-names>MH</given-names></name><name><surname>Ankrum</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>26463</elocation-id><pub-id pub-id-type="doi">10.1038/srep26463</pub-id><pub-id pub-id-type="pmid">27212469</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Krasnodembskaya</surname><given-names>A</given-names></name><name><surname>Kapetanaki</surname><given-names>M</given-names></name><name><surname>Mouded</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Serikov</surname><given-names>V</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mesenchymal stem cells enhance survival and bacterial clearance in murine <italic>Escherichia coli</italic> pneumonia</article-title><source>Thorax</source><volume>67</volume><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2011-201176</pub-id><pub-id pub-id-type="pmid">22250097</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haack-Sørensen</surname><given-names>M</given-names></name><name><surname>Kastrup</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cryopreservation and revival of mesenchymal stromal cells</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>698</volume><fpage>161</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1007/978-1-60761-999-4_13</pub-id><pub-id pub-id-type="pmid">21431518</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoogduijn</surname><given-names>MJ</given-names></name><name><surname>Popp</surname><given-names>F</given-names></name><name><surname>Verbeek</surname><given-names>R</given-names></name><name><surname>Masoodi</surname><given-names>M</given-names></name><name><surname>Nicolaou</surname><given-names>A</given-names></name><name><surname>Baan</surname><given-names>C</given-names></name><name><surname>Dahlke</surname><given-names>M-H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy</article-title><source>International Immunopharmacology</source><volume>10</volume><fpage>1496</fpage><lpage>1500</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2010.06.019</pub-id><pub-id pub-id-type="pmid">20619384</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooijmans</surname><given-names>CR</given-names></name><name><surname>Rovers</surname><given-names>MM</given-names></name><name><surname>de Vries</surname><given-names>RBM</given-names></name><name><surname>Leenaars</surname><given-names>M</given-names></name><name><surname>Ritskes-Hoitinga</surname><given-names>M</given-names></name><name><surname>Langendam</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SYRCLE’s risk of bias tool for animal studies</article-title><source>BMC Medical Research Methodology</source><volume>14</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2288-14-43</pub-id><pub-id pub-id-type="pmid">24667063</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>S</given-names></name><name><surname>Gaynard</surname><given-names>S</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Barry</surname><given-names>F</given-names></name><name><surname>Scully</surname><given-names>M</given-names></name><name><surname>O’Toole</surname><given-names>D</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Cytokine pre-activation of cryopreserved xenogeneic-free human mesenchymal stromal cells enhances resolution and repair following ventilator-induced lung injury potentially via a KGF-dependent mechanism</article-title><source>Intensive Care Medicine Experimental</source><volume>8</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s40635-020-0295-5</pub-id><pub-id pub-id-type="pmid">32025852</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>S</given-names></name><name><surname>Masterson</surname><given-names>C</given-names></name><name><surname>Brady</surname><given-names>J</given-names></name><name><surname>Loftus</surname><given-names>P</given-names></name><name><surname>Horan</surname><given-names>E</given-names></name><name><surname>O’Flynn</surname><given-names>L</given-names></name><name><surname>Elliman</surname><given-names>S</given-names></name><name><surname>Barry</surname><given-names>F</given-names></name><name><surname>O’Brien</surname><given-names>T</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>O’Toole</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Umbilical cord-derived CD362<sup>+</sup> mesenchymal stromal cells for <italic>E. coli</italic> pneumonia: impact of dose regimen, passage, cryopreservation, and antibiotic therapy</article-title><source>Stem Cell Research &amp; Therapy</source><volume>11</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-020-01624-8</pub-id><pub-id pub-id-type="pmid">32169108</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>S</given-names></name><name><surname>Gonzalez</surname><given-names>H</given-names></name><name><surname>Brady</surname><given-names>J</given-names></name><name><surname>Devaney</surname><given-names>J</given-names></name><name><surname>Scully</surname><given-names>M</given-names></name><name><surname>O’Toole</surname><given-names>D</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>12842</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222312842</pub-id><pub-id pub-id-type="pmid">34884645</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horiuchi</surname><given-names>K</given-names></name><name><surname>Ozeki</surname><given-names>N</given-names></name><name><surname>Endo</surname><given-names>K</given-names></name><name><surname>Mizuno</surname><given-names>M</given-names></name><name><surname>Katano</surname><given-names>H</given-names></name><name><surname>Akiyama</surname><given-names>M</given-names></name><name><surname>Tsuji</surname><given-names>K</given-names></name><name><surname>Koga</surname><given-names>H</given-names></name><name><surname>Sekiya</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Thawed cryopreserved synovial mesenchymal stem cells show comparable effects to cultured cells in the inhibition of osteoarthritis progression in rats</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>9683</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-89239-8</pub-id><pub-id pub-id-type="pmid">33958682</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Introna</surname><given-names>M</given-names></name><name><surname>Lucchini</surname><given-names>G</given-names></name><name><surname>Dander</surname><given-names>E</given-names></name><name><surname>Galimberti</surname><given-names>S</given-names></name><name><surname>Rovelli</surname><given-names>A</given-names></name><name><surname>Balduzzi</surname><given-names>A</given-names></name><name><surname>Longoni</surname><given-names>D</given-names></name><name><surname>Pavan</surname><given-names>F</given-names></name><name><surname>Masciocchi</surname><given-names>F</given-names></name><name><surname>Algarotti</surname><given-names>A</given-names></name><name><surname>Micò</surname><given-names>C</given-names></name><name><surname>Grassi</surname><given-names>A</given-names></name><name><surname>Deola</surname><given-names>S</given-names></name><name><surname>Cavattoni</surname><given-names>I</given-names></name><name><surname>Gaipa</surname><given-names>G</given-names></name><name><surname>Belotti</surname><given-names>D</given-names></name><name><surname>Perseghin</surname><given-names>P</given-names></name><name><surname>Parma</surname><given-names>M</given-names></name><name><surname>Pogliani</surname><given-names>E</given-names></name><name><surname>Golay</surname><given-names>J</given-names></name><name><surname>Pedrini</surname><given-names>O</given-names></name><name><surname>Capelli</surname><given-names>C</given-names></name><name><surname>Cortelazzo</surname><given-names>S</given-names></name><name><surname>D’Amico</surname><given-names>G</given-names></name><name><surname>Biondi</surname><given-names>A</given-names></name><name><surname>Rambaldi</surname><given-names>A</given-names></name><name><surname>Biagi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Treatment of graft versus host disease with mesenchymal stromal cells: A phase I study on 40 adult and pediatric patients</article-title><source>Biology of Blood and Marrow Transplantation</source><volume>20</volume><fpage>375</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.bbmt.2013.11.033</pub-id><pub-id pub-id-type="pmid">24321746</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MN</given-names></name><name><surname>Das</surname><given-names>SR</given-names></name><name><surname>Emin</surname><given-names>MT</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Westphalen</surname><given-names>K</given-names></name><name><surname>Rowlands</surname><given-names>DJ</given-names></name><name><surname>Quadri</surname><given-names>SK</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Bhattacharya</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury</article-title><source>Nature Medicine</source><volume>18</volume><fpage>759</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1038/nm.2736</pub-id><pub-id pub-id-type="pmid">22504485</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>YG</given-names></name><name><surname>Shin</surname><given-names>WH</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Chai</surname><given-names>JW</given-names></name><name><surname>Jeong</surname><given-names>EC</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Shim</surname><given-names>H</given-names></name><name><surname>Shin</surname><given-names>JS</given-names></name><name><surname>Shin</surname><given-names>IS</given-names></name><name><surname>Ra</surname><given-names>JC</given-names></name><name><surname>Oh</surname><given-names>S</given-names></name><name><surname>Yoon</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A proof-of-concept clinical trial</article-title><source>Stem Cells (Dayton, Ohio)</source><volume>32</volume><fpage>1254</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1002/stem.1634</pub-id><pub-id pub-id-type="pmid">24449146</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kebriaei</surname><given-names>P</given-names></name><name><surname>Hayes</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>A</given-names></name><name><surname>Uberti</surname><given-names>J</given-names></name><name><surname>Marks</surname><given-names>DI</given-names></name><name><surname>Soiffer</surname><given-names>R</given-names></name><name><surname>Waller</surname><given-names>EK</given-names></name><name><surname>Burke</surname><given-names>E</given-names></name><name><surname>Skerrett</surname><given-names>D</given-names></name><name><surname>Shpall</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease</article-title><source>Biology of Blood and Marrow Transplantation</source><volume>26</volume><fpage>835</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1016/j.bbmt.2019.08.029</pub-id><pub-id pub-id-type="pmid">31505228</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>IU</given-names></name><name><surname>Yoon</surname><given-names>Y</given-names></name><name><surname>Choi</surname><given-names>KU</given-names></name><name><surname>Jo</surname><given-names>KR</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>WH</given-names></name><name><surname>Kweon</surname><given-names>O-K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Therapeutic Effects of Intravenous Injection of Fresh and Frozen Thawed HO-1-Overexpressed Ad-MSCs in Dogs with Acute Spinal Cord Injury</article-title><source>Stem Cells International</source><volume>2019</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1155/2019/8537541</pub-id><pub-id pub-id-type="pmid">31481975</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koç</surname><given-names>ON</given-names></name><name><surname>Gerson</surname><given-names>SL</given-names></name><name><surname>Cooper</surname><given-names>BW</given-names></name><name><surname>Dyhouse</surname><given-names>SM</given-names></name><name><surname>Haynesworth</surname><given-names>SE</given-names></name><name><surname>Caplan</surname><given-names>AI</given-names></name><name><surname>Lazarus</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy</article-title><source>Journal of Clinical Oncology</source><volume>18</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1200/JCO.2000.18.2.307</pub-id><pub-id pub-id-type="pmid">10637244</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotobuki</surname><given-names>N</given-names></name><name><surname>Hirose</surname><given-names>M</given-names></name><name><surname>Machida</surname><given-names>H</given-names></name><name><surname>Katou</surname><given-names>Y</given-names></name><name><surname>Muraki</surname><given-names>K</given-names></name><name><surname>Takakura</surname><given-names>Y</given-names></name><name><surname>Ohgushi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells</article-title><source>Tissue Engineering</source><volume>11</volume><fpage>663</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1089/ten.2005.11.663</pub-id><pub-id pub-id-type="pmid">15998208</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Michaeloudes</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wiegman</surname><given-names>CH</given-names></name><name><surname>Adcock</surname><given-names>IM</given-names></name><name><surname>Lian</surname><given-names>Q</given-names></name><name><surname>Mak</surname><given-names>JCW</given-names></name><name><surname>Bhavsar</surname><given-names>PK</given-names></name><name><surname>Chung</surname><given-names>KF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>141</volume><fpage>1634</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2017.08.017</pub-id><pub-id pub-id-type="pmid">28911970</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Martin-Rendon</surname><given-names>E</given-names></name><name><surname>Watt</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions</article-title><source>Biotechnology Progress</source><volume>26</volume><fpage>1635</fpage><lpage>1643</lpage><pub-id pub-id-type="doi">10.1002/btpr.464</pub-id><pub-id pub-id-type="pmid">20572296</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohan</surname><given-names>P</given-names></name><name><surname>Murphy</surname><given-names>N</given-names></name><name><surname>Treacy</surname><given-names>O</given-names></name><name><surname>Lynch</surname><given-names>K</given-names></name><name><surname>Morcos</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Ryan</surname><given-names>AE</given-names></name><name><surname>Griffin</surname><given-names>MD</given-names></name><name><surname>Ritter</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2666</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02666</pub-id><pub-id pub-id-type="pmid">30515159</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luetzkendorf</surname><given-names>J</given-names></name><name><surname>Nerger</surname><given-names>K</given-names></name><name><surname>Hering</surname><given-names>J</given-names></name><name><surname>Moegel</surname><given-names>A</given-names></name><name><surname>Hoffmann</surname><given-names>K</given-names></name><name><surname>Hoefers</surname><given-names>C</given-names></name><name><surname>Mueller-Tidow</surname><given-names>C</given-names></name><name><surname>Mueller</surname><given-names>LP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation</article-title><source>Cytotherapy</source><volume>17</volume><fpage>186</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2014.10.018</pub-id><pub-id pub-id-type="pmid">25593077</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquez-Curtis</surname><given-names>LA</given-names></name><name><surname>Janowska-Wieczorek</surname><given-names>A</given-names></name><name><surname>McGann</surname><given-names>LE</given-names></name><name><surname>Elliott</surname><given-names>JAW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects</article-title><source>Cryobiology</source><volume>71</volume><fpage>181</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.cryobiol.2015.07.003</pub-id><pub-id pub-id-type="pmid">26186998</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Goolaerts</surname><given-names>A</given-names></name><name><surname>Howard</surname><given-names>JP</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mesenchymal stem cells for acute lung injury: preclinical evidence</article-title><source>Critical Care Medicine</source><volume>38</volume><fpage>S569</fpage><lpage>S573</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3181f1ff1d</pub-id><pub-id pub-id-type="pmid">21164399</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>LA</given-names></name><name><surname>Stewart</surname><given-names>DJ</given-names></name><name><surname>Mei</surname><given-names>SHJ</given-names></name><name><surname>Courtman</surname><given-names>D</given-names></name><name><surname>Watpool</surname><given-names>I</given-names></name><name><surname>Granton</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Dos Santos</surname><given-names>C</given-names></name><name><surname>Walley</surname><given-names>KR</given-names></name><name><surname>Winston</surname><given-names>BW</given-names></name><name><surname>Schlosser</surname><given-names>K</given-names></name><name><surname>Fergusson</surname><given-names>DA</given-names></name><collab>Canadian Critical Care Trials Group</collab><collab>Canadian Critical Care Translational Biology Group</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>197</volume><fpage>337</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1164/rccm.201705-1006OC</pub-id><pub-id pub-id-type="pmid">28960096</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>SHJ</given-names></name><name><surname>McCarter</surname><given-names>SD</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Parker</surname><given-names>CH</given-names></name><name><surname>Liles</surname><given-names>WC</given-names></name><name><surname>Stewart</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1</article-title><source>PLOS Medicine</source><volume>4</volume><elocation-id>e269</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0040269</pub-id><pub-id pub-id-type="pmid">17803352</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>SHJ</given-names></name><name><surname>Haitsma</surname><given-names>JJ</given-names></name><name><surname>Dos Santos</surname><given-names>CC</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>PFH</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Liles</surname><given-names>WC</given-names></name><name><surname>Stewart</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>182</volume><fpage>1047</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1164/rccm.201001-0010OC</pub-id><pub-id pub-id-type="pmid">20558630</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendicino</surname><given-names>M</given-names></name><name><surname>Bailey</surname><given-names>AM</given-names></name><name><surname>Wonnacott</surname><given-names>K</given-names></name><name><surname>Puri</surname><given-names>RK</given-names></name><name><surname>Bauer</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MSC-based product characterization for clinical trials: an FDA perspective</article-title><source>Cell Stem Cell</source><volume>14</volume><fpage>141</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.01.013</pub-id><pub-id pub-id-type="pmid">24506881</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitrus</surname><given-names>I</given-names></name><name><surname>Smagur</surname><given-names>A</given-names></name><name><surname>Fidyk</surname><given-names>W</given-names></name><name><surname>Czech</surname><given-names>M</given-names></name><name><surname>Prokop</surname><given-names>M</given-names></name><name><surname>Chwieduk</surname><given-names>A</given-names></name><name><surname>Glowala-Kosinska</surname><given-names>M</given-names></name><name><surname>Czerw</surname><given-names>T</given-names></name><name><surname>Sobczyk-Kruszelnicka</surname><given-names>M</given-names></name><name><surname>Mendrek</surname><given-names>W</given-names></name><name><surname>Michalak</surname><given-names>K</given-names></name><name><surname>Sadus-Wojciechowska</surname><given-names>M</given-names></name><name><surname>Najda</surname><given-names>J</given-names></name><name><surname>Holowiecki</surname><given-names>J</given-names></name><name><surname>Giebel</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study</article-title><source>Bone Marrow Transplantation</source><volume>53</volume><fpage>274</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/s41409-017-0056-6</pub-id><pub-id pub-id-type="pmid">29269805</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molendijk</surname><given-names>I</given-names></name><name><surname>Bonsing</surname><given-names>BA</given-names></name><name><surname>Roelofs</surname><given-names>H</given-names></name><name><surname>Peeters</surname><given-names>KCMJ</given-names></name><name><surname>Wasser</surname><given-names>MNJM</given-names></name><name><surname>Dijkstra</surname><given-names>G</given-names></name><name><surname>van der Woude</surname><given-names>CJ</given-names></name><name><surname>Duijvestein</surname><given-names>M</given-names></name><name><surname>Veenendaal</surname><given-names>RA</given-names></name><name><surname>Zwaginga</surname><given-names>J-J</given-names></name><name><surname>Verspaget</surname><given-names>HW</given-names></name><name><surname>Fibbe</surname><given-names>WE</given-names></name><name><surname>van der Meulen-de Jong</surname><given-names>AE</given-names></name><name><surname>Hommes</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease</article-title><source>Gastroenterology</source><volume>149</volume><fpage>918</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.06.014</pub-id><pub-id pub-id-type="pmid">26116801</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orozco</surname><given-names>L</given-names></name><name><surname>Munar</surname><given-names>A</given-names></name><name><surname>Soler</surname><given-names>R</given-names></name><name><surname>Alberca</surname><given-names>M</given-names></name><name><surname>Soler</surname><given-names>F</given-names></name><name><surname>Huguet</surname><given-names>M</given-names></name><name><surname>Sentís</surname><given-names>J</given-names></name><name><surname>Sánchez</surname><given-names>A</given-names></name><name><surname>García-Sancho</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results</article-title><source>Transplantation</source><volume>97</volume><elocation-id>e66</elocation-id><pub-id pub-id-type="doi">10.1097/TP.0000000000000167</pub-id><pub-id pub-id-type="pmid">24887752</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Simon</surname><given-names>JA</given-names></name><name><surname>López-Villar</surname><given-names>O</given-names></name><name><surname>Andreu</surname><given-names>EJ</given-names></name><name><surname>Rifón</surname><given-names>J</given-names></name><name><surname>Muntion</surname><given-names>S</given-names></name><name><surname>Diez Campelo</surname><given-names>M</given-names></name><name><surname>Sánchez-Guijo</surname><given-names>FM</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Valcarcel</surname><given-names>D</given-names></name><name><surname>Cañizo</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial</article-title><source>Haematologica</source><volume>96</volume><fpage>1072</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.3324/haematol.2010.038356</pub-id><pub-id pub-id-type="pmid">21393326</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlee</surname><given-names>D</given-names></name><name><surname>de Vos</surname><given-names>AF</given-names></name><name><surname>Scicluna</surname><given-names>BP</given-names></name><name><surname>Mancheño</surname><given-names>P</given-names></name><name><surname>de la Rosa</surname><given-names>O</given-names></name><name><surname>Dalemans</surname><given-names>W</given-names></name><name><surname>Nürnberg</surname><given-names>P</given-names></name><name><surname>Lombardo</surname><given-names>E</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human Adipose-Derived Mesenchymal Stem Cells Modify Lung Immunity and Improve Antibacterial Defense in Pneumosepsis Caused by Klebsiella pneumoniae</article-title><source>Stem Cells Translational Medicine</source><volume>8</volume><fpage>785</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1002/sctm.18-0260</pub-id><pub-id pub-id-type="pmid">31033196</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittenger</surname><given-names>MF</given-names></name><name><surname>Discher</surname><given-names>DE</given-names></name><name><surname>Péault</surname><given-names>BM</given-names></name><name><surname>Phinney</surname><given-names>DG</given-names></name><name><surname>Hare</surname><given-names>JM</given-names></name><name><surname>Caplan</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mesenchymal stem cell perspective: cell biology to clinical progress</article-title><source>NPJ Regenerative Medicine</source><volume>4</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1038/s41536-019-0083-6</pub-id><pub-id pub-id-type="pmid">31815001</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prockop</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs</article-title><source>Molecular Therapy</source><volume>25</volume><fpage>1748</fpage><lpage>1756</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2017.06.004</pub-id><pub-id pub-id-type="pmid">28647464</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robb</surname><given-names>KP</given-names></name><name><surname>Fitzgerald</surname><given-names>JC</given-names></name><name><surname>Barry</surname><given-names>F</given-names></name><name><surname>Viswanathan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency</article-title><source>Cytotherapy</source><volume>21</volume><fpage>289</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2018.10.014</pub-id><pub-id pub-id-type="pmid">30528726</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogulska</surname><given-names>O</given-names></name><name><surname>Tykhvynska</surname><given-names>O</given-names></name><name><surname>Revenko</surname><given-names>O</given-names></name><name><surname>Grischuk</surname><given-names>V</given-names></name><name><surname>Mazur</surname><given-names>S</given-names></name><name><surname>Volkova</surname><given-names>N</given-names></name><name><surname>Vasyliev</surname><given-names>R</given-names></name><name><surname>Petrenko</surname><given-names>A</given-names></name><name><surname>Petrenko</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Novel Cryopreservation Approach Providing Off-the-Shelf Availability of Human Multipotent Mesenchymal Stromal Cells for Clinical Applications</article-title><source>Stem Cells International</source><volume>2019</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1155/2019/4150690</pub-id><pub-id pub-id-type="pmid">31885604</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowley</surname><given-names>SD</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Yadock</surname><given-names>D</given-names></name><name><surname>Holmberg</surname><given-names>L</given-names></name><name><surname>Macleod</surname><given-names>B</given-names></name><name><surname>Heimfeld</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade</article-title><source>Cytotherapy</source><volume>1</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1080/0032472031000141303</pub-id><pub-id pub-id-type="pmid">20426544</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmenkari</surname><given-names>H</given-names></name><name><surname>Laitinen</surname><given-names>A</given-names></name><name><surname>Forsgård</surname><given-names>RA</given-names></name><name><surname>Holappa</surname><given-names>M</given-names></name><name><surname>Lindén</surname><given-names>J</given-names></name><name><surname>Pasanen</surname><given-names>L</given-names></name><name><surname>Korhonen</surname><given-names>M</given-names></name><name><surname>Korpela</surname><given-names>R</given-names></name><name><surname>Nystedt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study</article-title><source>Cytotherapy</source><volume>21</volume><fpage>175</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2018.11.011</pub-id><pub-id pub-id-type="pmid">30611671</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Yin</surname><given-names>W</given-names></name><name><surname>Cen</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Effectiveness of human mesenchymal stem cells derived from bone marrow cryopreserved for 23-25 years</article-title><source>Cryobiology</source><volume>64</volume><fpage>167</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.cryobiol.2012.01.004</pub-id><pub-id pub-id-type="pmid">22280954</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>AI</given-names></name><name><surname>Shou</surname><given-names>P</given-names></name><name><surname>Rabson</surname><given-names>AB</given-names></name><name><surname>Ren</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>How mesenchymal stem cells interact with tissue immune responses</article-title><source>Trends in Immunology</source><volume>33</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.it.2011.11.004</pub-id><pub-id pub-id-type="pmid">22227317</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somal</surname><given-names>A</given-names></name><name><surname>Bhat</surname><given-names>IA</given-names></name><name><surname>B</surname><given-names>I</given-names></name><name><surname>Singh</surname><given-names>AP</given-names></name><name><surname>Panda</surname><given-names>BSK</given-names></name><name><surname>Desingu</surname><given-names>PA</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Bharti</surname><given-names>MK</given-names></name><name><surname>Pal</surname><given-names>A</given-names></name><name><surname>Saikumar</surname><given-names>G</given-names></name><name><surname>Chandra</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>GT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of Cryopreservation on Caprine Fetal Adnexa Derived Stem Cells and Its Evaluation for Growth Kinetics, Phenotypic Characterization, and Wound Healing Potential in Xenogenic Rat Model</article-title><source>Journal of Cellular Physiology</source><volume>232</volume><fpage>2186</fpage><lpage>2200</lpage><pub-id pub-id-type="doi">10.1002/jcp.25731</pub-id><pub-id pub-id-type="pmid">27966782</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza-Moreira</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>JP</given-names></name><name><surname>Salkhordeh</surname><given-names>M</given-names></name><name><surname>Virgo</surname><given-names>J</given-names></name><name><surname>Florian</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>ABP</given-names></name><name><surname>Watpool</surname><given-names>I</given-names></name><name><surname>McIntyre</surname><given-names>L</given-names></name><name><surname>English</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>DJ</given-names></name><name><surname>Mei</surname><given-names>SHJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients</article-title><source>IScience</source><volume>25</volume><elocation-id>104188</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2022.104188</pub-id><pub-id pub-id-type="pmid">35402859</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Salkhordeh</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J-P</given-names></name><name><surname>McRae</surname><given-names>A</given-names></name><name><surname>Souza-Moreira</surname><given-names>L</given-names></name><name><surname>McIntyre</surname><given-names>L</given-names></name><name><surname>Stewart</surname><given-names>DJ</given-names></name><name><surname>Mei</surname><given-names>SHJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Thawed Mesenchymal Stem Cell Product Shows Comparable Immunomodulatory Potency to Cultured Cells In Vitro and in Polymicrobial Septic Animals</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>18078</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-54462-x</pub-id><pub-id pub-id-type="pmid">31792313</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>M</given-names></name><name><surname>Mei</surname><given-names>SHJ</given-names></name><name><surname>Wolfe</surname><given-names>D</given-names></name><name><surname>Champagne</surname><given-names>J</given-names></name><name><surname>Fergusson</surname><given-names>D</given-names></name><name><surname>Stewart</surname><given-names>DJ</given-names></name><name><surname>Sullivan</surname><given-names>KJ</given-names></name><name><surname>Doxtator</surname><given-names>E</given-names></name><name><surname>Lalu</surname><given-names>M</given-names></name><name><surname>English</surname><given-names>SW</given-names></name><name><surname>Granton</surname><given-names>J</given-names></name><name><surname>Hutton</surname><given-names>B</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Maybee</surname><given-names>A</given-names></name><name><surname>Walley</surname><given-names>KR</given-names></name><name><surname>Santos</surname><given-names>CD</given-names></name><name><surname>Winston</surname><given-names>B</given-names></name><name><surname>McIntyre</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis</article-title><source>EClinicalMedicine</source><volume>19</volume><elocation-id>100249</elocation-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2019.100249</pub-id><pub-id pub-id-type="pmid">31989101</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsubokawa</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>K</given-names></name><name><surname>Nakanishi</surname><given-names>C</given-names></name><name><surname>Zuka</surname><given-names>M</given-names></name><name><surname>Nohara</surname><given-names>A</given-names></name><name><surname>Ino</surname><given-names>H</given-names></name><name><surname>Fujino</surname><given-names>N</given-names></name><name><surname>Konno</surname><given-names>T</given-names></name><name><surname>Kawashiri</surname><given-names>M</given-names></name><name><surname>Ishibashi-Ueda</surname><given-names>H</given-names></name><name><surname>Nagaya</surname><given-names>N</given-names></name><name><surname>Yamagishi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>298</volume><fpage>H1320</fpage><lpage>H1329</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01330.2008</pub-id><pub-id pub-id-type="pmid">20154257</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>A</given-names></name><name><surname>Martín-Ferrero</surname><given-names>MA</given-names></name><name><surname>Del Canto</surname><given-names>F</given-names></name><name><surname>Alberca</surname><given-names>M</given-names></name><name><surname>García</surname><given-names>V</given-names></name><name><surname>Munar</surname><given-names>A</given-names></name><name><surname>Orozco</surname><given-names>L</given-names></name><name><surname>Soler</surname><given-names>R</given-names></name><name><surname>Fuertes</surname><given-names>JJ</given-names></name><name><surname>Huguet</surname><given-names>M</given-names></name><name><surname>Sánchez</surname><given-names>A</given-names></name><name><surname>García-Sancho</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial</article-title><source>Transplantation</source><volume>99</volume><fpage>1681</fpage><lpage>1690</lpage><pub-id pub-id-type="doi">10.1097/TP.0000000000000678</pub-id><pub-id pub-id-type="pmid">25822648</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vives</surname><given-names>J</given-names></name><name><surname>Oliver-Vila</surname><given-names>I</given-names></name><name><surname>Pla</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Quality compliance in the shift from cell transplantation to cell therapy in non-pharma environments</article-title><source>Cytotherapy</source><volume>17</volume><fpage>1009</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2015.02.002</pub-id><pub-id pub-id-type="pmid">25769789</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>Flannery</surname><given-names>R</given-names></name><name><surname>LeRoux-Williams</surname><given-names>M</given-names></name><name><surname>Tashkin</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A placebo-controlled, randomized trial of mesenchymal stem cells in COPD</article-title><source>Chest</source><volume>143</volume><fpage>1590</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1378/chest.12-2094</pub-id><pub-id pub-id-type="pmid">23172272</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Liu</surname><given-names>KD</given-names></name><name><surname>Zhuo</surname><given-names>H</given-names></name><name><surname>Caballero</surname><given-names>L</given-names></name><name><surname>McMillan</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Cosgrove</surname><given-names>K</given-names></name><name><surname>Vojnik</surname><given-names>R</given-names></name><name><surname>Calfee</surname><given-names>CS</given-names></name><name><surname>Lee</surname><given-names>J-W</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>Levitt</surname><given-names>J</given-names></name><name><surname>Wiener-Kronish</surname><given-names>J</given-names></name><name><surname>Bajwa</surname><given-names>EK</given-names></name><name><surname>Leavitt</surname><given-names>A</given-names></name><name><surname>McKenna</surname><given-names>D</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial</article-title><source>The Lancet. Respiratory Medicine</source><volume>3</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(14)70291-7</pub-id><pub-id pub-id-type="pmid">25529339</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>EJ</given-names></name><name><surname>Thirumala</surname><given-names>S</given-names></name><name><surname>Badhe-Buchanan</surname><given-names>SS</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Mathew</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Off the shelf cellular therapeutics: Factors to consider during cryopreservation and storage of human cells for clinical use</article-title><source>Cytotherapy</source><volume>18</volume><fpage>697</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2016.03.295</pub-id><pub-id pub-id-type="pmid">27173747</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yea</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>IJ</given-names></name><name><surname>Sym</surname><given-names>G</given-names></name><name><surname>Bae</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regeneration of a full-thickness defect of rotator cuff tendon with freshly thawed umbilical cord-derived mesenchymal stem cells in a rat model</article-title><source>Stem Cell Research &amp; Therapy</source><volume>11</volume><elocation-id>387</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-020-01906-1</pub-id><pub-id pub-id-type="pmid">32894193</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75053.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Méndez-Ferrer</surname><given-names>Simón</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The pre-clinical systematic review by Dave C et al. covers an important and highly debated topic, which is the advantages and disadvantages of the use of freshly cultured vs cryopreserved mesenchymal stromal cells (MSCs). The authors conduct an appropriate survey and bias analysis and focus their review on reported studies on animal models of inflammation. They conclude that there are no significant differences between freshly-isolated or cryopreserved MSCs in terms of their pre-clinical efficacy.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75053.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Méndez-Ferrer</surname><given-names>Simón</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Comparison of Freshly-Cultured versus Cryopreserved Mesenchymal Stem Cells in Animal Models of Inflammation: A Pre-Clinical Systematic Review&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Extend their systematic review to make it more comprehensive and obtain higher power of analysis. If the heterogeneity of studies and parameters available does not allow to perform cross-comparisons, the limitations of the conclusions and interpretations should be acknowledged.</p><p>2) Key parameters that were not available for all studies are the methods for cryopreservation and thawing before use. These have a direct impact on cell viability and activity and, if not available, the conclusions should be toned down.</p><p>3) Previous studies directly comparing freshly-culture vs cryopreserved MSCs or demonstrating impaired immunosuppressive properties (e.g. 10.3109/14653249.2011.623691 or 10.1002/stem.2415) are not cited or discussed.</p><p>4) The authors discuss the differential level of apoptosis (higher in cryopreserved MSCs, compared with freshly cultured cells). The possible role of apoptosis in the immunodulatory effects of MSCs (doi: 10.1126/scitranslmed.aam7828) should be discussed as well.</p><p>5) The authors should include studies administering human MSCs using immuno-compromised animals to avoid immune rejection. The rationale for excluding this group is not justified.</p><p>6) Further clarification on criteria used to assess the methodological rigor of the included studies is needed.</p><p>7) The impact of cryopreservation compared with many other experimental variables, such as route of administration, cell dose, cell sources, etc. should be discussed. The various administration routes should be considered particularly in the context of treatment of inflammatory diseases in pre-clinical animal models. The authors should acknowledge that reporting on differences for a single variable is unlikely to provide a measure of overall animal health and provide clinically meaningful information of the duration and severity of the disease course. The authors should place more emphasis on this point in the discussion and acknowledge pitfalls associated with focusing on any one outcome metric.</p><p>8) The impact of the study would be greatly improved if a meta-analysis was performed including a higher number of studies. More recent studies need to be included as well.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The manuscript by Dave et al., describes a systemic analysis of existing literature comparing the potency and efficacy of fresh vs. cryopreserved mesenchymal stem/stromal cells (MSCs) in preclinical disease models. The systemic analysis is properly executed and appropriately evaluates biases in reporting. Inclusion and exclusion criteria are well described and appear to be well justified. However, the studies included in the analysis are broad based with respect to disease type, cell source, route of administration, dose, and outcome measures used to evaluate efficacy are also highly variable. Due to this high degree of heterogeneity, a rigorous meta-analysis was not feasible. Therefore, the results of the study are limited in scope, and it is unclear if the conclusions of the study are clinically meaningful. Therefore, aspects of the study require clarification.</p><p>1. The literature search was not biased by language and the authors were careful to encompass the broad terminology used to describe MSCs in their search, which ensures all relevant studies were captured. Despite these efforts, only 15 studies were included and these encompassed an array of conditions, such as lung injury, sepsis, allergic airway inflammation, wound healing, neurological and ocular disease. Therefore, while the study addresses a focused question of clinical relevance, the analysis of such heterogeneous studies limits overall confidence in the reliability of the results.</p><p>2. The methods section does a good job of defining inclusion and exclusion criteria. However, if xenogeneic, syngeneic, autologous and allogeneic MSCs were included it is unclear why use of immuno-compromised animals was excluded. For example, studies administering human MSCs to mice often employ immuno-compromised animals to avoid immune rejection. The authors should explain their rationale for excluding this group.</p><p>3. Bias assessment included criteria related to reporting bias. However, since it is critical to exclude studies that employ inferior methodological approaches, the authors should provide further clarification on criteria used to assess the methodological rigor of the included studies.</p><p>4. The authors indicate that the duration of cryopreservation was not reported in half of the studies analyzed, and the remaining studies used varying durations. Since the authors do not rule out cryopreservation duration as a variable that influences potency/efficacy, the inconstancy between studies is a concern. This, coupled with the fact that variable methods were used to thaw cells, and viability of the final product varied significantly (60-97%), raises serious concerns about the reliability of the analysis. These concerns regarding cryopreservation are also relevant for many other variables, such as route of administration, cell dose, cell sources, etc.</p><p>5. The impact of the study would be improved if a meta-analysis was performed. However, due to the heterogeneity of the studies evaluated, differences between fresh vs. cryopreserved MSCs were converted to mean and standard deviation for each outcome measure, which is of limited significance. For example, reporting on differences for a single variable is unlikely to provide a measure of overall animal health and provide clinically meaningful information of the duration and severity of the disease course. The authors should place more emphasis on this point in the discussion and acknowledge pitfalls associated with focusing on any one outcome metric.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>In the present review, Dave et al., provide an innovative and eye-catching comparison on the efficacy between freshly-cultured and cryopreserved mesenchymal stem cells in the pre-clinical treatment of inflammatory diseases. As the authors focused on detailed analysis of both in-vivo pre-clinical and in-vitro MSC potency outcomes from those published studies until June, 2020, no significant difference was detected in pre-clinical efficacy between freshly-cultured and cryopreserved MSCs basing on a massive electronic search and bioinformatics analysis on the on-line literature databases. This review is well-structured and provide evidence for considering a cryopreserved MSC product in further clinical trials.</p><p>The various administration routes should be detailed analyzed for treating inflammatory diseases in pre-clinical animal models. Besides, more recent published studies in 2021 should be included.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75053.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Extend their systematic review to make it more comprehensive and obtain higher power of analysis. If the heterogeneity of studies and parameters available does not allow to perform cross-comparisons, the limitations of the conclusions and interpretations should be acknowledged.</p></disp-quote><p>Thank you. We have updated our search strategy to include all published studies that met our pre-specified eligibility criteria in our published protocol until January 13, 2022. We screened 775 additional studies; 3 of them met our inclusion/exclusion criteria and were included in our final analysis. We have included a line in the Results section which explains why we were not able to perform meta-analyses and have also added this limitation in the limitations paragraph in the Discussion section (Page 13 and Page 23).</p><disp-quote content-type="editor-comment"><p>2) Key parameters that were not available for all studies are the methods for cryopreservation and thawing before use. These have a direct impact on cell viability and activity and, if not available, the conclusions should be toned down.</p></disp-quote><p>Thank you for this comment. We agree that these are important parameters that may affect cell viability and function as we discussed in the Discussion section of the manuscript. We contacted authors to obtain additional information that was not reported in their studies. We have now also added this important point as a limitation in the limitations section (Page 22, Lines 340-342) and in the conclusion. We also further advise that reviewers and journal editors mandate these parameters as standardized reporting items in publications to enhance transparency, reproducibility, and the conclusions that can be drawn from these studies (in vitro, pre-clinical animal, and human clinical trials) (Page 21).</p><disp-quote content-type="editor-comment"><p>3) Previous studies directly comparing freshly-culture vs cryopreserved MSCs or demonstrating impaired immunosuppressive properties (e.g. 10.3109/14653249.2011.623691 or 10.1002/stem.2415) are not cited or discussed.</p></disp-quote><p>Thank you for this comment. These studies are notable within the field of MSC research and demonstrate important <italic>in-vitro</italic> findings that relate to impairment of MSC immunosuppressive properties due to cryopreservation. Our systematic review reports on <italic>in-vitro</italic> potency measures in studies of <italic>in-vivo</italic> models of inflammation as per the eligibility criteria in our published protocol (1). We have now cited these <italic>in-vitr</italic>o studies in the introduction section of our manuscript (Page 4).</p><disp-quote content-type="editor-comment"><p>4) The authors discuss the differential level of apoptosis (higher in cryopreserved MSCs, compared with freshly cultured cells). The possible role of apoptosis in the immunodulatory effects of MSCs (doi: 10.1126/scitranslmed.aam7828) should be discussed as well.</p></disp-quote><p>Thank- you. We have added the findings from this provocative study to our Discussion section (Page 20).</p><disp-quote content-type="editor-comment"><p>5) The authors should include studies administering human MSCs using immuno-compromised animals to avoid immune rejection. The rationale for excluding this group is not justified.</p></disp-quote><p>We excluded these animal models a priori from our pre-defined eligibility criteria in our published protocol because our primary aim was to examine the efficacy of cryopreserved versus freshly-cultured MSCs on measures of inflammation in animal models with an intact immune system. Furthermore, an intact immune system may be required for MSC immunomodulation via the host cytotoxic cell activity (2). We have added this information as the rationale for excluding these animals from the systematic review in the exclusion section (Page 7) of the manuscript.</p><disp-quote content-type="editor-comment"><p>6) Further clarification on criteria used to assess the methodological rigor of the included studies is needed.</p></disp-quote><p>SYRCLE risk of bias tool for animal studies contains 10 entries and are related to selection bias, performance bias, detection bias, attrition bias, reporting bias and other biases. Half these items are in agreement with the items in the Cochrane risk of bias tool. Most of the variations between the two tools are due to differences in design between RCTs and animal studies. To provide further clarification on the criteria used to assess the methodological rigor, we have included an additional table in the Supplementary files (Supplementary Table 2) that outlines the signaling questions employed to reach decisions about risk of bias within the 10 domains.</p><disp-quote content-type="editor-comment"><p>7) The impact of cryopreservation compared with many other experimental variables, such as route of administration, cell dose, cell sources, etc. should be discussed. The various administration routes should be considered particularly in the context of treatment of inflammatory diseases in pre-clinical animal models. The authors should acknowledge that reporting on differences for a single variable is unlikely to provide a measure of overall animal health and provide clinically meaningful information of the duration and severity of the disease course. The authors should place more emphasis on this point in the discussion and acknowledge pitfalls associated with focusing on any one outcome metric.</p></disp-quote><p>We were unable to perform several of the sub-groups that we had planned <italic>apriori</italic> in our published protocol due to the heterogeneity of the included studies and the lack of comprehensive reporting. We have now added further mention to this point in our results and Discussion sections (Page 13 and Page 21).</p><p>We agree that a single biological outcome in pre-clinical studies may not reflect overall animal health. However, if a certain biological outcome is known from human research to be part of the mechanistic/causal pathway related to the disease then this outcome may be considered an important surrogate for overall health. These biological outcomes in pre-clinical studies may also help to inform the exploration of them as predictive or prognostic variables in human clinical trials. We thank the reviewer for making this point. We have now discussed these points in the limitations section of the discussion (Page 23).</p><disp-quote content-type="editor-comment"><p>8) The impact of the study would be greatly improved if a meta-analysis was performed including a higher number of studies. More recent studies need to be included as well.</p></disp-quote><p>Please see responses to reviewer comment #1.References</p><p>1) Dave, C., McRae, A., Doxtator, E. <italic>et al.</italic> Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis. <italic>Syst Rev</italic> 9<bold>,</bold> 188 (2020). https://doi.org/10.1186/s13643-020-01437-z.</p><p>2) Galleu A, Riffo-Vasquez Y, Trento C, Lomas C, Dolcetti L, Cheung TS, et al. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci Transl Med 9, 416 (2017). Available from: https://www.science.org/doi/10.1126/scitranslmed.aam7828</p></body></sub-article></article>